---

🦷 ORAL PATHOLOGY - BONE PATHOLOGY

Complete Notes for 3rd Year BDS

---

CLASSIFICATION OF BONE DISEASES IN ORAL PATHOLOGY

BONE PATHOLOGY
├── A. Inflammatory Diseases of Bone
│   ├── Osteitis (Dry Socket / Alveolar Osteitis)
│   ├── Acute Suppurative Osteomyelitis
│   ├── Chronic Osteomyelitis
│   │   ├── Focal Sclerosing Osteomyelitis
│   │   └── Diffuse Sclerosing Osteomyelitis
│   ├── Osteoradionecrosis
│   └── Medication-Related Osteonecrosis (MRONJ)
├── B. Benign Fibro-Osseous Lesions (BFOLs)
│   ├── Fibrous Dysplasia (Monostotic / Polystotic)
│   ├── Ossifying Fibroma
│   └── Cemento-Osseous Dysplasias
│       ├── Periapical COD
│       ├── Focal COD
│       └── Florid COD
├── C. Giant Cell Lesions of the Jaw
│   ├── Central Giant Cell Granuloma (CGCG)
│   ├── Giant Cell Tumor
│   ├── Cherubism
│   └── Hyperparathyroidism (Brown Tumor)
└── D. Metabolic / Systemic Bone Disease
    └── Paget's Disease of Bone

---

PART A: INFLAMMATORY DISEASES OF BONE

1. OSTEITIS (DRY SOCKET / ALVEOLAR OSTEITIS)

---

2. OSTEOMYELITIS OF THE JAWS

Definition

Etiology

• Primary cause: Odontogenic infections and jaw fractures
• In Africa: Acute necrotizing gingivitis (NOMA) is an important cause
• Organisms: Polymicrobial (oral flora); Staphylococcus aureus is most common overall

Predisposing Factors

1. Chronic systemic diseases, immunocompromised states
2. Decreased vascularity of bone
3. Tobacco use, alcohol abuse, IV drug use
4. Diabetes mellitus
5. Exanthematous fever, malaria
6. Sickle cell anemia
7. Malnutrition
8. Malignancy
9. Collagen vascular disease
10. AIDS / HIV
11. Radiation (osteoradionecrosis)
12. Osteopetrosis, Paget's disease, end-stage cemento-osseous dysplasia (hypovascular bone)

Routes of Infection

1. Hematogenous spread (more common in children)
2. Extension from a contiguous site (most common in the jaws - from dental infection)
3. Direct implantation - after compound fractures or surgical procedures

---

A. ACUTE SUPPURATIVE OSTEOMYELITIS

• Systemic: fever, malaise, chills, leukocytosis
• Local: throbbing pain, swelling, trismus, loose teeth, pus discharge
• Numbness of lip (Vincent's symptom) due to involvement of inferior alveolar nerve
• Mandible > maxilla (due to denser cortical bone and poorer blood supply)

• Acute phase: bacteria proliferate + neutrophilic infiltrate
• Necrosis of bone cells and marrow within first 48 hours
• Bacteria + inflammation spread through Haversian systems to periosteum
• In children: periosteum loosely attached → subperiosteal abscess
• Lifting of periosteum → further ischemia → more necrosis
• Rupture of periosteum → soft tissue abscess → draining sinus

• Early: no radiographic changes (bone loss not visible until 30-50% mineral loss)
• Later: ill-defined lytic areas with moth-eaten appearance

• Antibiotics (penicillin, clindamycin, cephalexin, cefotaxime)
• Surgical drainage if abscess present
• Extraction of offending tooth

---

B. CHRONIC OSTEOMYELITIS

• Marrow fibrosis
• Sequestrum with empty lacunae
• Inflammatory infiltrate of lymphocytes and plasma cells (not neutrophils)
• Periosteal new bone formation (involucrum)

• Ill-defined radiolucency with areas of sclerosis
• Sequestrum appears as a dense radiopaque fragment surrounded by lucency
• Periosteal reaction (onion-skin appearance in some cases)

1. Pathologic fracture
2. Secondary (reactive) amyloidosis
3. Endocarditis
4. Sepsis
5. Squamous cell carcinoma in draining sinus tracts
6. Sarcoma in infected bone

• Long-term antibiotics
• Sequestrectomy + saucerization
• Decortication
• Hyperbaric oxygen (for refractory cases, osteoradionecrosis)
• Resection + reconstruction for persistent cases

---

C. FOCAL SCLEROSING OSTEOMYELITIS (Condensing Osteitis)

---

D. DIFFUSE SCLEROSING OSTEOMYELITIS

• Ill-defined, controversial diagnosis
• Characterized by: pain, inflammation, gnathic periosteal hyperplasia, sclerosis, and lucency
• Can be confused with florid cemento-osseous dysplasia or Paget's disease
• Treatment: antibiotics, NSAIDs, bisphosphonates; surgery in refractory cases

---

E. OSTEORADIONECROSIS (ORN)

---

F. MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ)

---

PART B: BENIGN FIBRO-OSSEOUS LESIONS (BFOLs)

Key concept: BFOLs share the same histopathology - cellular fibrous connective tissue with woven bone/osteoid/cementoid material. Radiographic correlation is critical to differentiate them.

---

1. FIBROUS DYSPLASIA

Definition

Pathogenesis (Robbins)

• Somatic gain-of-function mutations in GNAS1 gene (encodes Gs-protein alpha subunit)
• Same gene mutated in pituitary adenomas
• Constitutively active Gs-protein → ↑ cAMP → cellular proliferation + disrupted osteoblast differentiation
• Phenotype depends on stage of embryogenesis when mutation is acquired

Forms

Clinical Features (Jaw specific)

• Presents in childhood and adolescence (slow progressive bone enlargement)
• Usually stops enlarging at growth plate closure / puberty
• Painless bony expansion of jaw
• Maxilla > mandible for craniofacial FD
• "Ground glass" appearance on X-ray is characteristic
• Can cause facial asymmetry, malocclusion, eye problems

Radiology

• "Ground glass" or "orange peel" or "smoky/hazy" appearance (most characteristic)
• Ill-defined borders - blends with surrounding bone ("flows into" adjacent bone)
• No cortical expansion initially; bowing and thinning in advanced disease
• No periosteal reaction

Histology (Morphology - Robbins)

• Intramedullary lytic lesions with cortical thinning
• Tan-white and gritty on gross examination
• Curvilinear (C-shaped / Chinese letter shaped) trabeculae of woven bone
• WITHOUT a rim of osteoblasts (no osteoblastic rimming - key feature!)
• Surrounded by moderately cellular fibroblastic proliferation
• Cystic degeneration, hemorrhage, foamy macrophages may be seen
• Variant patterns: pagetoid (thick interconnected trabeculae) and hypercellular pattern

Treatment

• Monostotic: often no treatment; observation
• Symptomatic: curettage (recurrence is common), contouring surgery
• Bisphosphonates for pain reduction
• Surgery timed after puberty (when growth stabilizes)
• Rare complication: malignant transformation (sarcoma), especially with radiation history, McCune-Albright, or Mazabraud syndrome

---

2. OSSIFYING FIBROMA

Key Exam Comparison:

---

3. CEMENTO-OSSEOUS DYSPLASIAS (COD)

Three Types:

---

PART C: GIANT CELL LESIONS OF THE JAW

1. CENTRAL GIANT CELL GRANULOMA (CGCG)

Definition

Etiology and Pathogenesis

• Previously called "giant cell reparative granuloma" (thought to be reparative)
• Now considered a benign neoplasm due to unpredictable aggressive behavior and relationship to giant cell tumor of long bones
• Primary neoplastic cells are the fibroblasts/stromal cells; giant cells are reactive

Clinical Features

• Predominantly children and young adults
• Mandible > maxilla (ratio 2:1); anterior region most common
• Crosses the midline (characteristic feature)
• Painless slow expansion (non-aggressive type)
• Can be locally aggressive: pain, rapid growth, root resorption, cortical perforation

Two Behavioral Types:

Radiology

• Multilocular or unilocular radiolucency (soap-bubble or honeycomb appearance)
• Ill-defined or well-defined borders
• Root resorption and displacement of teeth

Histology

• Vascularized fibrous stroma with fibroblasts and hemosiderin deposits
• Multinucleated osteoclast-type giant cells (variable distribution - clustered near hemorrhagic areas)
• Foci of hemorrhage, hemosiderin pigment
• Woven bone formation at periphery

Differential Diagnosis

Treatment

• Non-aggressive: Curettage (treatment of choice)
• Aggressive: Resection may be needed
• Medical alternatives: intralesional corticosteroids, calcitonin, interferon-alpha (for aggressive cases)
• Recurrence rate: ~15-20% (higher in aggressive type)

Important: Always rule out hyperparathyroidism before diagnosing CGCG (Brown tumor is histologically identical!) - check serum calcium, PTH levels.

---

2. GIANT CELL TUMOR (GCT) OF THE JAW

---

3. CHERUBISM

Definition

Pathogenesis

• Mutation in SH3BP2 gene on chromosome 4
• Encodes a protein that activates osteoclasts → disrupted jaw morphogenesis
• Some consider it a genetically determined chronic noninfectious inflammatory disorder

Clinical Features

• Presents in early childhood (2-5 years)
• Bilateral symmetric enlargement of both jaws (most characteristic feature)
• Cheek puffing → cherub-like appearance (hence the name)
• Upward rotation of eyes → "eyes raised to heaven" appearance (due to orbital floor involvement)
• All four quadrants involved
• Missing, displaced, unerupted teeth

Radiology

• Bilateral multilocular radiolucencies of mandible and maxilla
• Giant cells + fibrous stroma (same as CGCG histologically)

Histology

• Vascularized fibrous stroma with multinucleated giant cells
• Eosinophilic perivascular cuffing of collagen surrounding capillaries (distinctive feature!)
• Mature lesions: large amounts of fibrous tissue, fewer giant cells

Prognosis and Treatment

• Self-limiting - lesions regress after puberty (usually by late teens)
• Generally good prognosis, especially if limited to mandible
• Surgical recontouring may be done after regression (for cosmetic reasons)
• No aggressive resection needed

---

4. BROWN TUMOR (Hyperparathyroidism)

---

PART D: METABOLIC BONE DISEASE

PAGET'S DISEASE OF BONE (Osteitis Deformans)

Definition

Epidemiology

• Age: >55 years (usually over 60)
• More prevalent in males (M:F ratio 2:1)
• Geographic distribution: UK, Germany, France, Australia; rare in Asia and Africa
• Accounts for only 0.05% of oral-maxillofacial pathologies

Pathogenesis (Three Phases)

1. Osteolytic phase: Aggressive osteoclastic bone resorption (osteoclasts are large, with many nuclei)
2. Mixed phase: Osteoclastic resorption + osteoblastic formation occurring simultaneously
3. Osteosclerotic phase: Predominantly osteoblastic formation; bone becomes hard, enlarged, brittle

Clinical Features - Systemic

• Often asymptomatic (found incidentally on X-ray or ↑ ALP)
• Bone pain and headaches (skull involvement)
• Bowing of tibia (saber shin)
• Pathologic fractures
• Hearing loss (compression of CN VIII)
• "Leonine facies" (lion-like face with skull involvement)
• Increased cardiac output (hypervascular bone acts as AV shunting) → high-output cardiac failure

Clinical Features - Jaw Specific

• Jaw enlargement (both jaws but maxilla > mandible)
• Teeth become widely spaced (spacing increases)
• Progressive ill-fitting dentures (classic complaint!)
• Hypercementosis (cementum apposition on roots) → ankylosis
• Difficulty/inability to extract teeth due to ankylosis

Radiology

• "Cotton wool" appearance (most characteristic) - alternating radiolucent and radiopaque areas
• Hypercementosis on roots
• Loss of lamina dura
• "Mosaic pattern" on histology (pathognomonic)

Histology (Pathognomonic)

• Mosaic pattern - lamellar bone trabeculae with irregular cement lines forming a "mosaic" or "jigsaw puzzle" pattern
• Osteoblastic-osteoclastic activity (mixed phase)
• Cemento-osseous trabeculae with multiple compartments
• Osteomyelitis can complicate (35% of jaw cases)

Lab Findings

• ↑ Serum Alkaline Phosphatase (ALP) - most significant marker of disease activity
• Normal serum calcium (usually)
• ↑ Urinary hydroxyproline (marker of bone collagen breakdown)

Complications

1. Pathologic fracture
2. Secondary osteomyelitis (especially of jaws)
3. Malignant transformation to osteosarcoma (in ~1% - but sarcoma prognosis very poor)
4. High-output cardiac failure
5. Hearing loss
6. Neurological compression

Treatment

• Bisphosphonates (alendronate, pamidronate, zoledronic acid) - main treatment; inhibit osteoclasts
• Calcitonin (older agent; less effective)
• Analgesics for pain
• Dental considerations: avoid extractions if possible (risk of osteomyelitis); pre-treat with antibiotics

---

QUICK COMPARISON TABLE: Giant Cell Lesions

---

QUICK COMPARISON TABLE: BFOLs

---

HIGH-YIELD EXAM POINTS

1. Sequestrum = dead bone; Involucrum = new bone shell around sequestrum
2. Fibrous dysplasia = GNAS1 mutation; curvilinear bone trabeculae WITHOUT osteoblastic rimming; "ground glass" X-ray
3. Ossifying fibroma = WELL-DEFINED borders; osteoblastic rimming PRESENT; enucleates cleanly
4. CGCG = anterior mandible, crosses midline, multinucleated giant cells + fibrous stroma; ALWAYS rule out hyperparathyroidism
5. Cherubism = SH3BP2 gene; bilateral; self-limiting; eosinophilic perivascular cuffing on histology
6. Paget's disease = "cotton wool" X-ray; mosaic pattern histology; ↑ ALP; hypercementosis; ill-fitting dentures
7. Brown tumor = histologically identical to CGCG; treat the systemic disease (hyperparathyroidism)
8. MRONJ = bisphosphonates most commonly implicated; mandible > maxilla; prevent with dental clearance before starting drug
9. Florid COD = risk of secondary osteomyelitis if traumatized/exposed; no treatment otherwise
10. McCune-Albright = polyostotic FD + café-au-lait spots + precocious puberty (all three together)

---

---

• 6 inflammatory conditions (osteitis through MRONJ) with full clinical + histological details
• 3 BFOLs (fibrous dysplasia, ossifying fibroma, COD) with the critical comparison table
• 4 giant cell lesions with distinguishing histological features
• Paget's disease with jaw-specific features
• Comparison tables and high-yield exam points throughout

1. You upload your past year question papers (PDF, image, or text)
2. You tell me your preferred books (e.g., Shafer's, Neville's, Rajendran & Sivapathasundharam, Cawson's, etc.)
3. I answer each question in structured format based on those books - definition, etiology, histology, clinical features, treatment, exactly like a model answer

• Upload your past year question paper (photo, PDF, or just type out the questions)
• I'll answer each one in structured bullet-point format following Shafer's and Neville's content

• The library I have access to does include Robbins Pathology and several other medical references - Shafer's and Neville's specifically aren't in it, but I know their content well and will answer faithfully to their frameworks (definitions, classifications, histological descriptions, and clinical emphasis that these books use)
• For any question where Shafer's and Neville's differ in classification or terminology, I'll flag both

1. Write about fibrous dysplasia 2. Classify osteomyelitis and describe chronic osteomyelitis 3. Short note on Paget's disease

---

📚 ORAL PATHOLOGY - 10 MARK LONG ESSAY ANSWERS

Based on Shafer's Oral Pathology & Neville's Oral & Maxillofacial Pathology

---

Q1. Categorize the cysts of odontogenic origin. Discuss the etiology, clinical features, radiographic and histopathologic features, treatment, and prognosis of Odontogenic Keratocyst (OKC).

---

CLASSIFICATION OF ODONTOGENIC CYSTS

1. Dentigerous cyst
2. Odontogenic Keratocyst (OKC)
3. Lateral periodontal cyst
4. Botryoid odontogenic cyst
5. Gingival cyst of adults
6. Gingival cyst of newborns (Epstein pearls / Bohn's nodules)
7. Eruption cyst
8. Calcifying epithelial odontogenic cyst (Gorlin cyst / CCOT)
9. Orthokeratinized odontogenic cyst (OOC)
10. Glandular odontogenic cyst (Sialo-odontogenic cyst)

1. Radicular cyst (Periapical cyst)
2. Residual cyst
3. Paradental cyst (Inflammatory collateral cyst)
4. Buccal bifurcation cyst

---

ODONTOGENIC KERATOCYST (OKC)

Introduction

• OKC is a benign, unicystic, developmental odontogenic cyst of the jaw
• Arises from remnants of the dental lamina (cell rests of Serres)
• Previously classified as a tumor by WHO (2005) and renamed Keratocystic Odontogenic Tumor (KCOT), but reclassified back to cyst in WHO 2017
• Has the most aggressive behavior of all odontogenic cysts

---

Etiology and Pathogenesis

• Arises from: remnants of dental lamina and possibly from basal cells of overlying oral epithelium
• Genetic basis:
  • Mutation of PTCH1 tumor suppressor gene (chromosome 9q22.3) - same gene mutated in Gorlin syndrome (Nevoid Basal Cell Carcinoma Syndrome - NBCCS)
  • PTCH1 is a component of the Hedgehog signaling pathway
  • Loss of PTCH1 → uncontrolled cell proliferation
• Sporadic vs. Syndromic:
  • Sporadic: single OKC
  • NBCCS (Gorlin-Goltz syndrome): multiple OKCs + basal cell carcinomas + skeletal anomalies + calcification of falx cerebri

---

Clinical Features

• Age: Most common in 2nd and 3rd decades; peak incidence 10-40 years; second smaller peak in older adults
• Sex: Males > females (2:1)
• Site: Mandible (75%) >> maxilla; posterior body and ramus of mandible is most common location
• Maxillary lesions more common in the anterior region
• Usually asymptomatic - discovered incidentally on routine radiograph
• When symptomatic: pain, swelling, drainage; may cause cortical perforation
• Tends to grow in an anteroposterior direction along the medullary canal without significant bony expansion (unlike dentigerous cysts)
• May be associated with an unerupted tooth (especially mandibular third molar)
• NBCCS / Gorlin Syndrome features (when multiple OKCs present):
  • Multiple OKCs (often the first manifestation)
  • Multiple basal cell carcinomas of the skin
  • Calcification of falx cerebri (intracranial)
  • Bifid ribs, vertebral anomalies
  • Frontal/parietal bossing
  • Hypertelorism, orbital dystopia

---

Radiographic Features

• Shape: Unilocular (more common) or multilocular radiolucency
• Borders: Well-defined, corticated, scalloped margins
• Teeth: May involve an unerupted tooth (mimics dentigerous cyst); root resorption is uncommon (compared to other cysts - an important feature)
• Characteristic tendency to grow along medullary canal without causing significant jaw expansion
• Multilocular lesions show "soap-bubble" or "honeycomb" appearance
• CT / CBCT: important for extent of lesion, cortical integrity, and surgical planning

---

Histopathological Features

• Thin, uniform parakeratinized stratified squamous epithelium of 6-8 cell layers
• Flat epithelio-connective tissue interface (no rete ridges) - this is key!
• Basal cell layer: Hyperchromatic, palisaded columnar/cuboidal cells with nuclei polarized away from the basement membrane ("tombstone" or "picket-fence" appearance)
• Superficial layer: Corrugated (wavy) parakeratinized surface
• "Budding" or "satellite cysts" (daughter cysts) in the fibrous wall - explains high recurrence

• Thin, uninflamed fibrous wall
• May contain satellite cysts, islands of odontogenic epithelium in the wall
• Inflammation (if present) causes loss of typical features → diagnostic difficulty

• Cheesy/creamy white material = keratin debris
• Thin watery fluid with low soluble protein content (<4 g/dL) - helps distinguish from dentigerous and radicular cysts

---

Treatment

1. Enucleation + curettage (most common) - careful removal of cyst lining
2. Marsupialization - decompression to reduce size before definitive surgery; useful in large lesions in children
3. Enucleation + Carnoy's solution application to the bony cavity (chemical fixation of residual epithelium) - reduces recurrence
4. Peripheral ostectomy (burring of bony walls after enucleation)

• Carnoy's solution (3g FeCl3, 6mL glacial acetic acid, 1mL absolute alcohol, 10mL chloroform)
• Liquid nitrogen cryotherapy
• Electrocautery of bony walls

---

Prognosis

• Recurrence rate: 25-62% (highest of all odontogenic cysts) - due to:
  1. Thin, fragile lining that tears easily during removal
  2. Satellite cysts / daughter cysts in the wall left behind
  3. Extension into cancellous bone
  4. Possibility of new cyst formation from dental lamina rests
• Recurrence typically within 5 years of surgery
• Long-term follow-up (minimum 5-10 years) with periodic radiographs mandatory
• Malignant transformation to SCC is rare but documented
• NBCCS cases: lifelong surveillance required; dermatology, neurology, and ophthalmology involvement

---

Q2. Classify benign and malignant epithelial tumors. Describe oral squamous cell carcinoma (OSCC).

---

CLASSIFICATION OF EPITHELIAL TUMORS OF THE ORAL CAVITY

1. Squamous papilloma
2. Verruca vulgaris (oral wart)
3. Condyloma acuminatum
4. Focal epithelial hyperplasia (Heck's disease)
5. Keratoacanthoma

1. Leukoplakia
2. Erythroplakia
3. Oral submucous fibrosis
4. Oral lichen planus
5. Actinic cheilosis
6. Palatal lesions in reverse smokers

1. Squamous cell carcinoma (SCC) - most common (90-95%)
2. Verrucous carcinoma
3. Spindle cell carcinoma
4. Basaloid SCC
5. Adenosquamous carcinoma
6. Nasopharyngeal carcinoma (non-keratinizing)
7. Lymphoepithelial carcinoma
8. Undifferentiated carcinoma

---

ORAL SQUAMOUS CELL CARCINOMA (OSCC)

Introduction

• Most common malignant neoplasm of the oral cavity (90-95% of all oral cancers)
• Arises from the stratified squamous epithelium of the oral mucosa
• Represents a major public health problem especially in South and Southeast Asia

---

Epidemiology

• Incidence: ~300,000+ cases per year worldwide
• Age: Most common 5th-7th decade; increasing incidence in younger patients (HPV-associated)
• Sex: Males > females; but the gap is narrowing
• Geography: High incidence in India, Southeast Asia (betel quid use), France (alcohol), Brazil

---

Etiology and Risk Factors

• Smoking: cigarettes, bidis, pipes, cigars
• Smokeless tobacco: chewing tobacco, snuff, khaini, mawa
• Reverse smoking (associated with palatal SCC)
• Carcinogens: polycyclic aromatic hydrocarbons, nitrosamines → DNA adduct formation

• Independent risk factor; synergistic with tobacco (10-15x increased risk when combined)
• Mechanism: direct solvent effect on mucosa, acetaldehyde (toxic metabolite), nutritional deficiencies, immunosuppression

• Major risk factor in India and SE Asia
• Arecoline (alkaloid) → submucous fibrosis → malignant transformation
• Associated with buccal mucosa SCC

• HPV-16 and HPV-18 most implicated (oncogenic types)
• HPV E6 protein → degrades p53 tumor suppressor
• HPV E7 protein → inactivates pRb (retinoblastoma protein)
• HPV-associated OSCC: younger patients, non-smokers, oropharynx (base of tongue, tonsil) more than oral cavity proper

• UV radiation → actinic cheilosis → carcinoma of the lip (vermillion border)

• Ill-fitting dentures, sharp tooth edges, chronic trauma (less clear evidence)

• Iron deficiency (Plummer-Vinson syndrome) → post-cricoid SCC, lateral tongue
• Vitamin A and B complex deficiencies

• Organ transplant recipients, HIV/AIDS patients have higher risk

• Leukoplakia (especially non-homogeneous/speckled), erythroplakia (highest malignant potential ~50%)

---

Molecular Pathogenesis

• p53 mutation (most common - in ~50% of OSCC)
• EGFR overexpression (in >90% of OSCC)
• Cyclin D1 amplification
• Loss of p16/CDKN2A (allows uncontrolled G1-S transition)
• Loss of heterozygosity at 3p, 9p, 17p, 13q
• Microsatellite instability

---

Clinical Features

1. Lateral border and ventral surface of tongue (most common)
2. Floor of the mouth
3. Lower lip (vermillion border)
4. Soft palate and tonsillar pillars
5. Buccal mucosa (especially in betel quid chewers)
6. Gingiva and alveolar ridge

• Persistent white patch (leukoplakia), red patch (erythroplakia), or mixed (speckled leukoplakia)
• Painless ulcer that fails to heal
• Indurated (firm, rolled) margins
• Patient may be asymptomatic

• Deep, indurated ulcer with raised, everted, rolled margins
• Central necrosis and sloughing
• Pain (especially on swallowing - odynophagia; or spontaneous)
• Bleeding
• Fixation to underlying tissues
• Paresthesia (inferior alveolar nerve involvement → numbness of lip)
• Trismus (pterygoid muscle involvement)
• Dysphagia, dysarthria
• Cervical lymphadenopathy (ipsilateral > bilateral)
• Weight loss, cachexia (late features)

---

TNM Staging (AJCC)

---

Histopathological Features

• Islands, nests, cords of malignant squamous cells invading the connective tissue
• Keratin pearls (squamous pearls) - concentric whorls of keratinized cells with pink center
• Individual cell keratinization
• Nuclear hyperchromatism, pleomorphism, increased N:C ratio
• Abnormal mitotic figures (tripolar, quadripolar)
• Intercellular bridges (prickles) between cells
• Desmoplastic stromal reaction
• Perineural and lymphovascular invasion (worse prognosis)
• Inflammatory infiltrate at the invasive front

---

Diagnosis

• Biopsy (incisional) with histopathology - gold standard
• Toluidine blue staining - vital staining to identify suspicious areas
• Exfoliative cytology (Papanicolaou stain)
• Fine Needle Aspiration Cytology (FNAC) for nodal assessment
• CT/MRI for local extent and nodal involvement
• PET scan for distant metastasis

---

Treatment

• Wide local excision with 1.5-2 cm clear margins
• Neck dissection (selective, modified radical, or radical) for nodal involvement
• Mandibulectomy/maxillectomy if bone involved

• Primary treatment for inaccessible lesions or non-surgical candidates
• Adjuvant post-surgery for high-risk features (positive margins, perineural invasion, N2+ disease)

• Cisplatin-based concurrent chemoradiation for advanced cases
• Cetuximab (anti-EGFR antibody) for EGFR-overexpressing tumors

• EGFR inhibitors (cetuximab)
• Immunotherapy (pembrolizumab, nivolumab) for recurrent/metastatic disease

---

Prognosis

• 5-year survival rate: ~50-60% overall; Stage I ~80-90%, Stage IV ~20-30%
• Poor prognostic factors: Advanced stage, poorly differentiated histology, perineural invasion, lymphovascular invasion, positive margins, regional/distant metastasis
• Tongue and floor of mouth have worse prognosis
• Lip carcinoma has best prognosis (early detection, accessible site)

---

Q3. Classify fibro-osseous lesions. Describe the etiology, clinical, radiologic, and histopathological features of fibrous dysplasia.

---

CLASSIFICATION OF BENIGN FIBRO-OSSEOUS LESIONS (BFOLs)

1. Monostotic fibrous dysplasia
2. Polyostotic fibrous dysplasia
   • McCune-Albright syndrome
   • Mazabraud syndrome

1. Conventional ossifying fibroma
2. Juvenile ossifying fibroma
   • Trabecular juvenile ossifying fibroma
   • Psammomatoid juvenile ossifying fibroma

1. Periapical cemento-osseous dysplasia (Periapical COD)
2. Focal cemento-osseous dysplasia
3. Florid cemento-osseous dysplasia
4. Familial gigantiform cementoma

---

FIBROUS DYSPLASIA

Introduction

• A benign developmental condition (not a true neoplasm) resulting from a localized arrest in bone maturation
• Characterized by replacement of normal bone by an abnormal fibro-osseous tissue
• Reflects an abnormality in bone-forming mesenchyme

---

Etiology and Pathogenesis

• Genetic cause: Somatic gain-of-function mutation in the GNAS1 gene (chromosome 20q13) - encodes the alpha subunit of the Gs stimulatory protein
• Mutation → constitutively active Gs-alpha protein → ↑ intracellular cAMP → abnormal osteoblast differentiation + increased osteoclastic activity
• The mutation occurs in a single cell during embryogenesis; extent of disease depends on the developmental stage at which mutation occurs (earlier = more widespread/polyostotic)
• NOT inherited - all forms result from post-zygotic (somatic) mutations
• GNAS1 mutation can be confirmed by genetic testing on lesional tissue

---

Clinical Features

• Presents in childhood and adolescence (6-20 years)
• Lesion grows with the patient and typically stabilizes at puberty/skeletal maturity
• Painless, gradual, progressive bony expansion
• More common in females (especially polyostotic)

• Maxilla > mandible (unlike most jaw lesions)
• Presents as a slowly enlarging bony hard swelling causing facial asymmetry
• May cause narrowing of the nasal passage, orbital displacement (proptosis), visual disturbance
• Displacement of teeth and malocclusion
• Obliteration of the maxillary sinus

• Single bone involved; 70-80% of all cases
• Jaw (craniofacial) involvement in ~20-25% of monostotic cases
• Usually asymptomatic or mild symptoms

• Multiple bones involved; may cause significant deformity
• Limb deformities, bowing of long bones (shepherd's crook deformity of femur)
• Higher risk of pathologic fractures

1. Polyostotic fibrous dysplasia
2. Café-au-lait skin macules with irregular ("coast of Maine") borders
3. Endocrine abnormalities - precocious puberty (most common), hyperthyroidism, acromegaly, Cushing syndrome

• Fibrous dysplasia + intramuscular myxomas

---

Radiographic Features

• "Ground glass" appearance - the most characteristic and classic radiographic finding
  • Also described as "orange peel," "smoky," "cloudy," or "hazy" appearance
  • Due to the disorganized woven bone and fibroblastic tissue
• Borders: Ill-defined - lesion blends imperceptibly with surrounding normal bone (unlike ossifying fibroma which has well-defined borders) - this is a KEY differentiator
• Cortical thinning and expansion in larger lesions
• No periosteal reaction
• Displacement (but rarely resorption) of tooth roots
• Narrowing of maxillary sinus (in maxillary lesions)
• "Leonine" appearance of skull with advanced polyostotic involvement
• In late sclerotic stage: diffuse radiopacity

---

Histopathological Features

• Tan-white, gritty tissue replacing normal marrow
• Slightly glistening cut surface

1. Bone trabeculae:
   • Irregularly shaped, curvilinear ("C"-shaped) or angular trabeculae of woven (immature) bone
   • Often described as "Chinese characters" or "alphabet soup" pattern - highly characteristic
   • NO OSTEOBLASTIC RIMMING around the trabeculae (this is the single most important diagnostic histological feature, differentiating FD from ossifying fibroma)
   • Woven bone (not lamellar) - confirmed by polarized light microscopy
2. Fibrous stroma:
   • Moderately cellular, loosely arranged fibroblastic proliferation
   • Bland, spindle-shaped fibroblasts
   • Richly vascular
3. Additional features:
   • Cystic degeneration
   • Hemorrhagic foci
   • Foamy (lipid-laden) macrophages
   • Secondary aneurysmal bone cyst formation may occur
   • Pagetoid pattern variant: thick, interconnected bone trabeculae
   • Hypercellular pattern: parallel bone trabeculae with numerous osteocytes and polarized osteoblastic rimming (rare variant)

---

Differential Diagnosis

---

Treatment and Prognosis

• Monostotic, asymptomatic: Observation; annual radiographic surveillance
• Symptomatic or deforming: Surgical contouring/recontouring (reshaping)
  • Best performed after puberty when the lesion stabilizes
  • Curettage has high recurrence (fibrous tissue grows back)
• Bisphosphonates (pamidronate IV) - used for pain management in polyostotic disease
• Radiation therapy is CONTRAINDICATED - significantly increases risk of malignant transformation to sarcoma
• Malignant transformation:
  • Rare (<1%), mainly in polyostotic disease
  • Risk increased by: prior radiation, McCune-Albright syndrome, Mazabraud syndrome
  • Transforms to osteosarcoma, fibrosarcoma, or chondrosarcoma
  • Warning signs: rapid growth, new pain, nerve paresthesia, sudden radiographic changes

---

Q4. Classify odontogenic cysts. Describe the clinical and histopathological features of calcifying epithelial odontogenic cyst (CEOC).

---

CALCIFYING EPITHELIAL ODONTOGENIC CYST (CEOC)

Introduction

• First described by Gorlin et al. in 1962 → hence called "Gorlin cyst"
• A benign developmental odontogenic cyst with characteristic ghost cell formation and calcification
• WHO 2017 classification: retained as a cyst (CEOC); previously classified as a tumor (CCOT) in 2005
• Has a solid neoplastic counterpart: Dentinogenic Ghost Cell Tumor (DGCT)

---

Etiology

• Arises from reduced enamel epithelium, odontogenic epithelial cell rests, or surface epithelium
• Ghost cells are thought to arise from abnormal keratinization of odontogenic epithelial cells

---

Variants (Praetorius Classification)

1. Cystic type (CEOC) - more common
2. Neoplastic solid type (DGCT) - rare, locally aggressive

---

Clinical Features

• Age: Wide age range; bimodal distribution - peaks in 2nd decade and >50 years
• Sex: No significant sex predilection
• Site: Maxilla and mandible equally affected; anterior region most common (incisor-canine area)
  • ~75% intraosseous; ~25% extraosseous (peripheral, in gingiva)
• Presents as a slow-growing, painless bony swelling
• May be associated with an unerupted or impacted tooth (in ~30% of cases)
• Peripheral lesions appear as a firm gingival mass; may be pink to bluish
• Rarely: pain, numbness (large lesions compressing nerves)
• May be found incidentally on routine radiograph

---

Radiographic Features

• Intraosseous lesions: Unilocular well-defined radiolucency (most common)
• May contain irregular calcifications within the radiolucent area - characteristic "flecks of calcification" scattered throughout
• Appearance can range from: purely radiolucent → mixed radiolucent-radiopaque → mostly radiopaque (as calcification increases)
• May be associated with an unerupted tooth (resembles dentigerous cyst)
• May contain a complex odontoma within the cystic lumen
• Root resorption is uncommon

---

Histopathological Features

• Thin, odontogenic epithelium with:
  • Cuboidal to columnar basal cells with reverse nuclear polarity (similar to ameloblastoma)
  • Overlying loosely arranged cells resembling stellate reticulum of enamel organ
• Most characteristic feature: Presence of "ghost cells" (anucleate, eosinophilic, shadow epithelial cells)
  • Ghost cells = epithelial cells that have undergone abnormal keratinization → lose their nuclei → appear as pale/eosinophilic "ghost" outlines
  • May coalesce to form large sheets
  • May undergo calcification (dystrophic calcification) → basophilic calcified masses

• Fibrous connective tissue
• Foreign body giant cell reaction around ghost cells and calcified material (when ghost cells rupture into stroma)
• Dentinoid or dysplastic dentin may be found in the connective tissue wall (occasionally with complex odontoma)
• Inflammatory infiltrate if secondarily infected

1. Odontogenic epithelial lining with ameloblastoma-like basal cells
2. Ghost cells (anucleate, eosinophilic)
3. Calcification within/around ghost cells + foreign body giant cell reaction

---

Differential Diagnosis

• Dentigerous cyst (when associated with unerupted tooth, non-calcified)
• Ameloblastoma (due to similar basal cells)
• Calcifying epithelial odontogenic tumor / Pindborg tumor (no ghost cells; Liesegang rings)
• Odontoma

---

Treatment and Prognosis

• Treatment: Surgical enucleation and curettage
• Prognosis: Excellent; low recurrence rate (~2%) for the cystic type
• The neoplastic solid variant (DGCT) is more aggressive with higher recurrence (~72%)
• Rare malignant transformation (ghost cell odontogenic carcinoma) reported
• Regular follow-up recommended

---

Q5 / Q6 / Q7 / Q10. Classify odontogenic tumors. Describe ameloblastoma in detail - clinical, radiographic, histopathological features, histologic variants, treatment, and a note on malignant ameloblastoma.

---

CLASSIFICATION OF ODONTOGENIC TUMORS

1. Ameloblastoma (conventional/solid-multicystic)
2. Unicystic ameloblastoma
3. Peripheral (extraosseous) ameloblastoma
4. Metastasizing ameloblastoma
5. Ameloblastic carcinoma
6. Squamous odontogenic tumor
7. Calcifying epithelial odontogenic tumor (Pindborg tumor)
8. Adenomatoid odontogenic tumor (AOT)
9. Keratocystic odontogenic tumor (reclassified back to cyst in 2017)

1. Ameloblastic fibroma
2. Ameloblastic fibroodontoma
3. Primordial odontogenic tumor
4. Odontoma (compound and complex)
5. Dentinogenic ghost cell tumor

1. Odontogenic fibroma
2. Odontogenic myxoma / myxofibroma
3. Cementoblastoma

1. Ameloblastic carcinoma
2. Primary intraosseous SCC
3. Sclerosing odontogenic carcinoma
4. Clear cell odontogenic carcinoma
5. Ghost cell odontogenic carcinoma
6. Odontogenic carcinosarcoma
7. Odontogenic sarcomas

---

AMELOBLASTOMA

Introduction

• The most common clinically significant odontogenic tumor
• Benign, locally aggressive, epithelial odontogenic tumor
• Arises from: enamel organ, remnants of dental lamina (cell rests of Serres), reduced enamel epithelium, oral epithelium, or epithelial lining of odontogenic cysts
• First described by Broca (1868); termed "ameloblastoma" by Churchill (1934)
• MAPK pathway mutations (BRAF V600E most common) in ~90% of conventional ameloblastomas

---

Classification of Ameloblastoma (WHO 2017)

1. Conventional (solid/multicystic) ameloblastoma - most common
2. Unicystic ameloblastoma
3. Peripheral (extraosseous) ameloblastoma
4. Metastasizing ameloblastoma

---

A. CONVENTIONAL (SOLID/MULTICYSTIC) AMELOBLASTOMA

Clinical Features

• Most common type (>85% of ameloblastomas)
• Age: 3rd-5th decade; mean age ~35-40 years
• Sex: Males = females (slight male predominance in some studies)
• Site: Mandible (85%) >> maxilla; posterior mandible (molar-ramus region) most common
• Maxillary lesions: tend to be more aggressive, involve sinuses and skull base
• Presents as a slow-growing, painless swelling causing facial asymmetry
• Eventually causes cortical expansion ("eggshell crackling" on palpation)
• Advanced: pain, paresthesia, pathologic fracture, loosening/displacement of teeth
• NEVER causes numbness early (unlike malignancy) - this helps clinically
• Growth is relentless - does not stop at puberty

---

Radiographic Features

• Classic appearance: "Soap-bubble" or "honeycomb" multilocular radiolucency - large lesions
• Smaller lesions: unilocular radiolucency (may mimic dentigerous cyst)
• Well-defined corticated margins that are often scalloped (scalloping between tooth roots - "bay-like recesses")
• Root resorption of adjacent teeth - more common than other ODTs (important feature)
• Cortical expansion with thinning
• "Eggshell" thin cortex
• May be associated with an unerupted tooth
• CT/CBCT: shows extent of cortical destruction, relationship to mandibular canal

---

Histopathological Features

1. Follicular pattern (most common)
2. Plexiform pattern (second most common)

• Peripheral columnar/tall cells with:
  • Reverse nuclear polarity - nuclei polarized away from the basement membrane (toward the center of the cell, not toward the BM) - KEY diagnostic feature
  • Subnuclear vacuolization of cytoplasm
  • Palisading (stacked arrangement like piano keys)
• Central loosely arranged stellate cells resembling the stellate reticulum of enamel organ
• No enamel or dentin formation (unlike mixed odontogenic tumors)

---

Histologic Variants

---

B. UNICYSTIC AMELOBLASTOMA

• Accounts for ~15% of ameloblastomas
• Younger patients: 2nd-3rd decade
• Mandibular posterior region; often associated with unerupted third molar (mimics dentigerous cyst)
• Radiography: unilocular well-defined radiolucency (corticated)
• Vickers and Gorlin criteria (microscopic):
  • Columnar basal cells with subnuclear vacuolization
  • Palisading and reverse nuclear polarity
  • Overlying stellate reticulum-like cells

• Luminal - ameloblastomatous changes confined to luminal surface
• Intraluminal - nodular proliferation into lumen
• Mural - ameloblastomatous epithelium invades fibrous wall (worst prognosis; treat like solid)

---

C. PERIPHERAL AMELOBLASTOMA

• Extraosseous; arises from basal cell layer of surface epithelium or from superficial dental lamina rests
• Presents as a sessile or pedunculated gingival mass (painless)
• Radiography: Superficial cupping of alveolar bone (no true intraosseous involvement)
• Histology: same as conventional ameloblastoma
• Treatment: local excision; lowest recurrence of all types

---

Treatment

• Recurrence: Conventional - 50-90% after curettage; 15-25% after resection
• Unicystic: 10-20% recurrence overall
• Long-term follow-up (5-10 years minimum) mandatory

---

D. NOTE ON MALIGNANT AMELOBLASTOMA

• A conventional ameloblastoma (benign histology) that metastasizes to distant sites
• Also called "metastasizing ameloblastoma"
• Metastasis site: lung most common (hematogenous), also lymph nodes, bone
• The metastatic deposits show benign histology - they look like normal ameloblastoma, NOT carcinoma
• Mechanism of metastasis despite benign histology is unclear (possibly microaspiration)
• Treatment: surgery for primary + treatment of metastasis (surgery/radiation)

• Shows malignant cytologic features in the primary tumor (nuclear pleomorphism, atypical mitoses, necrosis)
• De novo or arising in a pre-existing ameloblastoma
• More aggressive behavior: rapid growth, cortical destruction, perineural invasion
• Radiography: poorly defined, destructive lesion
• Treatment: wide surgical resection + radiation + chemotherapy
• Prognosis: poor (5-year survival ~30-40%)

---

Q8 / Q9. Classify odontogenic tumors. Describe Adenomatoid Odontogenic Tumor (AOT) in detail.

---

ADENOMATOID ODONTOGENIC TUMOR (AOT)

Introduction

• A benign, well-encapsulated, slow-growing odontogenic tumor
• Characterized by duct-like (adenomatoid) structures within a spindle cell stroma
• Considered a hamartoma rather than a true neoplasm by some authors
• Previously called "ameloblastic adenomatoid tumor" or "pseudo-ameloblastoma"
• The tumor grows slowly and does not invade - hence very good prognosis
• Famous exam mnemonic: "Two-thirds disease" (see clinical features)

---

Etiopathogenesis

• Arises from: stratum intermedium of the enamel organ (most accepted theory)
• Alternatively: remnants of the dental lamina or from reduced enamel epithelium
• Not associated with any specific genetic mutations
• Considered by some as a hamartoma (developmental malformation) given its limited growth potential

---

Classification (Types)

---

Clinical Features - "TWO-THIRDS RULE" (high-yield exam point)

• 2/3 occur in females
• 2/3 occur in the anterior jaw
• 2/3 are associated with an unerupted tooth (usually maxillary canine)
• 2/3 occur in the maxilla
• 2/3 occur in patients under 20 years (most common in 2nd decade; range 5-30 years)

• Usually presents as a small, asymptomatic, slow-growing swelling
• May cause facial asymmetry with large lesions
• Associated with failure of eruption of the permanent canine (maxillary canine most common)
• Pain is uncommon
• Root divergence of adjacent teeth (displacement, not resorption)
• Peripheral type: firm, sessile pink gingival mass

---

Radiographic Features

• Well-defined, unilocular radiolucency
• Surrounds the crown and part of the root of an unerupted tooth (in contrast: dentigerous cyst only surrounds the crown to the CEJ)
• This is important: AOT extends below the CEJ onto the root - a key radiographic distinguisher from dentigerous cyst
• Faint calcifications may be seen within the radiolucency (snowflake/flecks of calcification)

• Well-defined unilocular radiolucency between or at the roots of teeth
• Calcifications may be visible

• AOT radiolucency extends below the cemento-enamel junction (CEJ)
• Dentigerous cyst stops exactly at the CEJ

---

Histopathological Features

• Well-encapsulated tumor with a thick fibrous capsule
• Solid or partly cystic

• Spindle-shaped and polyhedral epithelial cells arranged in nodular sheets or whorled masses

• Epithelial cells arranged to form duct-like (tubular) structures lined by tall columnar cells
• These are NOT true glands - no secretory function
• Nuclei polarized away from the lumen (similar to ameloblastoma)
• Hence the name "adeno-matoid" (gland-like, not actual gland)

• "Amyloid-like material" (eosinophilic homogeneous material) adjacent to the duct-like structures
• Whorled/ring-like calcifications ("Liesegang rings") - dystrophic calcification
• Calcified masses may coalesce

• Groups of epithelial cells arranged around a central space (tubular/rosette pattern)

• Sparse, loose fibrous stroma
• No dentin or enamel formation (even though named "odontogenic")

1. Spindle cells in whorled masses
2. Duct-like (adenomatoid) structures with tall columnar epithelial cells
3. Amyloid-like material + Liesegang ring calcifications
4. Rosette formations

---

Differential Diagnosis

• Dentigerous cyst (radiographically; but AOT extends below CEJ, dentigerous doesn't)
• Ameloblastoma (histologically some overlap; but AOT has duct-like structures and calcification)
• Calcifying epithelial odontogenic tumor (CEOT/Pindborg) (Liesegang rings similar, but CEOT lacks duct-like structures and has ghost cells)

---

Treatment and Prognosis

• Treatment: Simple surgical enucleation - the tumor shells out easily due to its thick capsule
• Unlike ameloblastoma, does NOT invade bone
• Recurrence: Extremely rare (virtually no recurrence)
• Prognosis: Excellent - cure with enucleation
• No malignant potential reported

---

Q11. Classify oral potentially malignant disorders (OPMDs). Describe oral lichen planus.

---

CLASSIFICATION OF ORAL POTENTIALLY MALIGNANT DISORDERS (OPMDs)

1. Leukoplakia
2. Erythroplakia (highest risk - ~50%)
3. Erythroleukoplakia (speckled leukoplakia)
4. Oral submucous fibrosis
5. Actinic cheilosis/cheilitis
6. Oral lichen planus (erosive type)
7. Palatal lesions in reverse smokers

1. Dyskeratosis congenita
2. Discoid lupus erythematosus
3. Sideropenic dysphagia (Plummer-Vinson syndrome)
4. Tertiary syphilis (luetic glossitis)

---

ORAL LICHEN PLANUS (OLP)

Introduction

• A chronic, immunologically mediated, mucocutaneous disease affecting the oral mucosa
• Characterized by T-lymphocyte-mediated destruction of basal keratinocytes
• Frequency: 0.2-3% of the general population
• An oral potentially malignant disorder (malignant transformation ~1-2%, mainly erosive type)

---

Etiology and Pathogenesis

1. Cell-mediated immune response:
   • Antigenic alteration of basal keratinocytes → T-cell recognition
   • CD8+ cytotoxic T cells are the predominant cells in the infiltrate (majority of lesional T cells)
   • CD4+ helper T cells also present
   • T cells express α-1 integrin molecules
2. Antigen presentation:
   • Lesional dendritic cells process and present antigens to CD4+ T cells
   • Keratinocytes aberrantly express MHC class II molecules → present antigens to CD4+ T cells
   • Activated CD8+ cytotoxic T cells → keratinocyte apoptosis (programmed death of basal cells)
3. Non-specific mechanisms:
   • Matrix metalloproteinase activation
   • Mast cell degranulation
   • Basement membrane alterations → fibrinogen deposition (important for DIF diagnosis)
   • Pro-inflammatory cytokines: RANTES, TNF-α, IFN-γ recruit inflammatory cells
   • Laminin, fibronectin, type 4 and 7 collagen upregulation
4. Triggering factors:
   • Emotional stress/anxiety
   • Drugs (lichenoid drug reactions): NSAIDs, beta-blockers, ACE inhibitors, antimalarials, gold, methyldopa
   • Dental materials: amalgam, gold (contact hypersensitivity)
   • Hepatitis C virus (strong association, especially in Mediterranean populations)
   • Diabetes mellitus (controversial)
   • Hypertension (controversial - "DEN" triad: Diabetes, Erosive OLP, Hypertension = Grinspan syndrome)

---

Clinical Features

• Age: Most common in middle-aged adults (40-60 years); rare in children
• Sex: Women > men (up to 75% female in some series)
• Distribution: Classically bilateral and symmetric (bilaterality is very characteristic)
• Most common site: buccal mucosa (bilateral), followed by tongue dorsum, gingiva, lips, palate

• "Desquamative gingivitis" - diffuse erythema and desquamation of attached gingiva
• Most commonly erosive or atrophic type
• Needs to be differentiated from mucous membrane pemphigoid and pemphigus vulgaris

---

Histopathological Features

• Hyperkeratosis (ortho or para) - in reticular and plaque types
• Irregular acanthosis or atrophy (erosive/atrophic types)
• "Saw-tooth" rete pegs - rete ridges pointed at the base (specific to OLP)
• Civatte bodies (Colloid/hyaline/cytoid bodies):
  • Eosinophilic, homogeneous, round to oval bodies
  • Found in the lower epithelium or superficial lamina propria
  • Represent apoptotic keratinocytes (liquefaction degeneration of basal cells)
  • Pathognomonic feature of lichen planus
• Liquefaction degeneration (vacuolar degeneration) of the basal cell layer - destruction of basal cells by cytotoxic T cells

• Band-like (lichenoid) infiltrate of lymphocytes (predominantly T cells) in the superficial lamina propria - tightly packed, confined to the upper lamina propria (like a "band" or "stripe")
• Predominance of CD8+ T lymphocytes in the infiltrate
• Blood vessels not particularly prominent

• Disrupted; irregular
• Fibrinogen deposition (important for DIF)

1. Hyperkeratosis + saw-tooth rete pegs
2. Band-like lymphocytic infiltrate in upper lamina propria
3. Civatte bodies + liquefaction degeneration of basal cells

---

Immunofluorescence

• Direct Immunofluorescence (DIF):
  • Fibrinogen deposited in a shaggy/irregular pattern along the basement membrane zone - highly characteristic
  • IgM, IgA, IgG may also be present in cytoid bodies
  • This pattern helps distinguish OLP from pemphigus (IgG intercellular) and MMP (IgG linear BM)

---

Malignant Potential

• OLP is an OPMD with ~1-2% malignant transformation rate (higher in erosive/atrophic forms)
• Transformation to oral squamous cell carcinoma
• Higher risk: erosive type, tongue involvement, tobacco/alcohol use, longer duration
• Regular follow-up every 6 months mandatory for erosive OLP

---

Treatment

• No treatment required
• Patient education + reassurance
• Periodic surveillance

• First line: Topical corticosteroids
  • Triamcinolone acetonide 0.1% in orobase
  • Fluocinonide gel 0.05%
  • Clobetasol propionate 0.05%
• Second line: Intralesional corticosteroids (for resistant cases)
• Systemic corticosteroids (prednisone) - for widespread severe lesions
• Calcineurin inhibitors:
  • Tacrolimus 0.1% ointment (topical immunosuppressant)
  • Pimecrolimus cream
• Other: Dapsone, hydroxychloroquine, retinoids, cyclosporine rinses
• Hepatitis C management if associated
• Remove causative drugs (if lichenoid drug reaction)
• Eliminate stress, treat associated systemic conditions

---

Q12. Classify salivary gland tumors. Write in detail about the aetiopathogenesis, clinical features, and histopathological features of mucoepidermoid carcinoma.

---

CLASSIFICATION OF SALIVARY GLAND TUMORS

1. Pleomorphic adenoma (most common salivary gland tumor overall)
2. Myoepithelioma
3. Basal cell adenoma
4. Warthin's tumor (Papillary cystadenoma lymphomatosum)
5. Oncocytoma
6. Lymphadenoma
7. Canalicular adenoma
8. Sebaceous adenoma
9. Ductal papilloma
10. Cystadenoma

1. Mucoepidermoid carcinoma (most common salivary gland malignancy)
2. Adenoid cystic carcinoma (most common in minor glands; worst prognosis)
3. Acinic cell carcinoma
4. Polymorphous adenocarcinoma (polymorphous low-grade adenocarcinoma)
5. Clear cell carcinoma
6. Basal cell adenocarcinoma
7. Intraductal carcinoma
8. Adenocarcinoma NOS
9. Salivary duct carcinoma
10. Myoepithelial carcinoma
11. Epithelial-myoepithelial carcinoma
12. Carcinoma ex pleomorphic adenoma
13. Secretory carcinoma
14. Sebaceous adenocarcinoma
15. Carcinosarcoma

• Hemangioma, lymphangioma, lipoma (benign)
• Sarcomas (malignant)

• Lymphoma (primary salivary gland)

---

MUCOEPIDERMOID CARCINOMA (MEC)

Introduction

• Most common malignant neoplasm of the salivary glands (35-50% of all salivary gland malignancies)
• First described by Stewart, Foote, and Becker in 1945
• Can arise from major and minor salivary glands
• Also the most common pediatric salivary gland malignancy
• Characterized by three cell types: mucous, epidermoid (squamoid), and intermediate cells

---

Aetiopathogenesis

• Arises from excretory duct reserve cells (intercalated duct cells or excretory duct basal cells)
• These cells have the potential to differentiate into mucous, squamoid, or intermediate cell types

• MAML2 gene fusion - most important molecular change
  • t(11;19)(q21;p13) translocation → CRTC1-MAML2 fusion gene
  • Present in ~40-80% of cases
  • MAML2 is a transcriptional coactivator of Notch signaling pathway
  • CRTC1-MAML2 fusion → constitutive activation of CREB and Notch pathways → cell proliferation
  • Tumors with MAML2 fusion: tend to be low/intermediate grade, better prognosis
  • Tumors without MAML2 fusion: higher grade, worse prognosis
• EGFR amplification (in high-grade MEC)
• TP53 mutations (in aggressive MEC)
• HER2/ERBB2 amplification

• Prior radiation exposure (post-radiation MEC can occur, especially in parotid)
• No specific dietary or lifestyle risk factors identified
• Rarely, arises within the walls of dentigerous cysts or from intraosseous sites (central MEC of jaws - considered odontogenic in origin)

---

Clinical Features

• Sex: Slightly more common in women (female predominance)
• Age: Mean age ~45 years; wide range; can occur in children (most common salivary carcinoma in children)
• Site:
  • Parotid gland most common (major gland) - ~45-50% of cases
  • Minor salivary glands - hard palate most common intraoral site
  • Also: buccal mucosa, retromolar trigone, floor of mouth, lip
  • Submandibular and sublingual glands less commonly
  • Central (intraosseous) MEC - rare; mandible > maxilla; considered odontogenic

• Slow-growing, painless mass (most common presentation)
• Parotid: firm, mobile lump in the parotid region
• Intraoral minor gland: bluish, fluctuant, painless submucosal mass - may mimic a mucocele (due to cystic mucin-containing spaces)
• Usually no facial nerve involvement (distinguishing from high-grade)

• Rapid growth
• Pain (perineural invasion)
• Facial nerve palsy (if parotid - involvement of facial nerve)
• Fixation to skin or deep structures
• Ulceration of overlying mucosa
• Regional lymphadenopathy (cervical nodes)
• Distant metastasis (lungs, bone, liver) in advanced cases

---

Histopathological Features

• Mixture of cystic and solid components
• Cystic areas: Lined predominantly by mucous cells with mucinous secretion filling the lumen (may give bluish color clinically)
• Solid areas: Sheets and nests of intermediate cells, with scattered epidermoid and mucous cells
• Duct-like structures also present

• PAS (Periodic Acid Schiff): Highlights mucin in mucous cells
• Mucicarmine: Stains mucin red
• Alcian blue: Stains acid mucins

• AFIP (Armed Forces Institute of Pathology) scoring system
• Brandwein grading system
• SEQ (Stricturing of epithelial quality) criteria

• Solid sheets of intermediate cells with minimal mucous differentiation
• No cystic change
• Markedly atypical nuclei, frequent mitoses

---

Differential Diagnosis

• Mucocele (intraoral; no epithelial lining in extravasation type)
• Necrotizing sialometaplasia (especially hard palate; reactive, not malignant)
• Adenocarcinoma NOS
• Adenosquamous carcinoma (true keratinization present)
• Warthin's tumor (for low-grade MEC in parotid)

---

Staging and Prognosis

• AJCC TNM staging applied
• Low-grade: Excellent prognosis; 5-year survival >90%
• Intermediate-grade: ~70-80% 5-year survival
• High-grade: Poor prognosis; 5-year survival ~40-50%
• Parotid and minor gland MECs have generally better prognosis than submandibular MECs
• Central (intraosseous) MEC: Less aggressive than conventional MEC; favorable prognosis

• Surgical excision with adequate margins (primary treatment)
• Neck dissection for high-grade or N+ cases
• Radiation therapy adjuvant for high-grade, positive margins, or perineural invasion
• Chemotherapy for metastatic/recurrent disease
• EGFR inhibitors under investigation

---

📋 SUMMARY OF ALL 12 ANSWERS

---

• Q5, Q6, Q7, and Q10 are all variations of the same question (Ameloblastoma) - the single answer above covers all four
• Q8 and Q9 are also the same (AOT) - one answer covers both
• Always write the classification first before describing the specific lesion - examiners give marks for it

---

📚 ORAL PATHOLOGY - 10 MARK LONG ESSAY ANSWERS

Source: Shafer's Oral Pathology (7th Ed.) + Mastering the BDS - Hemant Gupta

---

Q13. Classify salivary gland tumors. Write in detail about the clinical features and histopathology of mucoepidermoid carcinoma.

CLASSIFICATION OF SALIVARY GLAND TUMORS

1. Pleomorphic adenoma (Mixed tumor) - most common
2. Monomorphic adenomas:
   • Warthin's tumor (Papillary cystadenoma lymphomatosum)
   • Oxyphil adenoma (Oncocytoma)
   • Basal cell adenoma
   • Canalicular adenoma
   • Clear cell adenoma
3. Myoepithelioma

1. Mucoepidermoid carcinoma - most common malignant
2. Adenoid cystic carcinoma
3. Acinic cell carcinoma
4. Adenocarcinoma
5. Carcinoma ex pleomorphic adenoma (malignant mixed tumor)
6. Squamous cell carcinoma (primary)
7. Undifferentiated carcinoma
8. Polymorphous low-grade adenocarcinoma

• Hemangioma, lymphangioma, neurofibroma (benign)
• Sarcomas (malignant)

---

MUCOEPIDERMOID CARCINOMA

Introduction (Shafer's)

• First described by Masson and Berger (1924); term "mucoepidermoid carcinoma" coined by Stewart, Foote, and Becker (1945)
• Most common malignant salivary gland tumor (30-35% of all salivary malignancies)
• Has both mucous and epidermoid (squamoid) cell components - hence the name
• Can behave as low-grade or high-grade malignancy

---

Clinical Features (Shafer's Chapter on Salivary Gland Pathology)

• Most common salivary gland malignancy in both adults and children
• Age: wide range; mean ~45 years; most common salivary malignancy in the pediatric age group
• Sex: slight female predominance

• Parotid gland - most common site (45-50%)
• Minor salivary glands - hard palate most common intraoral site; also buccal mucosa, retromolar pad, lips, floor of mouth
• Submandibular gland (less common)
• Central (intraosseous) MEC - arises within the jaw bones, especially mandible; believed to arise from entrapped salivary gland tissue or from the lining of dentigerous cysts

• Slow-growing, painless fluctuant or firm submucosal mass
• Intraoral lesions may appear bluish (due to mucin-filled cysts beneath mucosa) → clinically resembles a mucocele
• Mobile, well-circumscribed
• No facial nerve involvement
• No lymphadenopathy typically

• Rapid growth with pain
• Facial nerve paralysis (parotid involvement)
• Fixation to adjacent tissues
• Ulceration of overlying skin or mucosa
• Cervical lymphadenopathy
• Distant metastasis (lung, bone, liver)

• Presents as swelling of jaw with pain
• Cortical expansion
• Radiograph: unilocular or multilocular radiolucency - may appear cystic
• Associated with an unerupted tooth in some cases

---

Histopathological Features (Shafer's - detailed)

• Cystic areas: Lined by mucous cells; filled with mucinous secretion; impart bluish color clinically
• Solid areas: Sheets and nests of intermediate and epidermoid cells
• Mixture of cystic and solid elements is characteristic
• Duct-like structures formed by epidermoid and intermediate cells

• Predominantly cystic (>25% cystic component)
• Abundant mucous cells (>20%)
• Minimal cytologic atypia
• Rare mitoses
• Minimal solid component
• No perineural/vascular invasion

• Equal cystic and solid components
• Moderate mucous cells
• Moderate atypia
• Occasional mitoses

• Predominantly solid pattern
• Few mucous cells (<10%) - mucin may be absent or scant
• Marked nuclear pleomorphism and atypia
• Frequent and atypical mitoses
• Perineural invasion, lymphovascular invasion
• Areas of necrosis
• Difficult to distinguish from poorly differentiated SCC

• Mucicarmine - stains mucin in mucous cells red (confirms diagnosis in high-grade MEC where mucin may be scant)
• PAS (Periodic Acid Schiff) - highlights mucin
• Alcian blue - stains acid mucopolysaccharides

• Necrotizing sialometaplasia (intraoral)
• Mucocele (clinical)
• Adenosquamous carcinoma (has true keratinization - absent in MEC)
• Squamous cell carcinoma (no mucous cells)

• Surgical excision with adequate margins
• Neck dissection for high-grade or N+ cases
• Adjuvant radiotherapy for high-grade lesions
• Low-grade: 5-year survival >90%; High-grade: ~40-50%

---

Q14. Classify salivary gland tumors. Describe the etiology, clinical features, radiographic features, histopathologic findings, treatment, and prognosis of pleomorphic adenoma.

---

PLEOMORPHIC ADENOMA (MIXED TUMOR)

Introduction (Shafer's)

• Most common benign salivary gland tumor (45-75% of all salivary gland tumors)
• Called "mixed tumor" because it contains both epithelial and mesenchymal (stromal) elements
• Term "pleomorphic adenoma" preferred over "mixed tumor" as the mixed appearance is due to metaplastic change, not two separate germ layers
• First described by Minssen (1874); name introduced by Willis (1953)

---

Etiology (Shafer's)

• Chromosome 8q12 abnormality - rearrangement of the PLAG1 gene (Pleomorphic Adenoma Gene 1) - most common molecular change
  • PLAG1 overexpression → transcription factor activation → cell proliferation
• 12q13-15 translocation - involving HMGA2 gene in another subset
• Prior radiation exposure - increases risk of salivary gland tumors
• Arises from: intercalated duct reserve cells or myoepithelial cells of the salivary gland
• The "biphasic" appearance results from the totipotential nature of intercalated duct cells which can differentiate into both epithelial and myoepithelial cells; the latter can further undergo mesenchymal metaplasia

---

Clinical Features (Shafer's)

• 60-70% of all parotid tumors are pleomorphic adenomas
• 40-60% of submandibular tumors
• ~50% of minor salivary gland tumors

• Wide age range; peak in 3rd-6th decade (most common in 4th decade)
• Slight female predominance (F:M = 3:2)

• Parotid gland - most common (most are in the superficial lobe; tail of parotid most common location)
• Submandibular gland
• Minor salivary glands - hard palate is the most common intraoral site; also lip (upper lip > lower lip), buccal mucosa, tongue

• Presents as a slow-growing, painless, firm, mobile swelling
• Duration: months to years (often >1 year before presentation)
• Parotid lesion: Swelling in pre-auricular region or at the angle of jaw; NO facial nerve involvement (important distinguishing feature from malignancy)
• Hard palate lesion: Smooth, dome-shaped submucosal swelling; surface mucosa normal; usually on one side of midline
• Lip lesion: Submucous firm nodule
• Untreated lesion may grow very large (giant pleomorphic adenoma) but remains benign
• No lymphadenopathy, no pain (unless secondary infection or malignant transformation)

---

Radiographic Features (for parotid and intraoral lesions)

• Plain X-ray: Not routinely helpful; may show calcifications within tumor (characteristic of pleomorphic adenoma when present)
• Sialography: Round, smooth filling defect (ball-in-hand appearance) in the duct system; displacement of ducts without destruction
• CT scan: Well-defined, homogeneous or heterogeneous mass; enhances with contrast; may show calcifications
• MRI: T1 - intermediate signal; T2 - high signal (due to myxoid/chondroid stroma); well-defined margins; no bone destruction
• Ultrasound: Well-defined, hypoechoic, lobulated mass; posterior acoustic enhancement
• Intraoral radiograph (hard palate): Smooth saucer-like erosion of underlying bone (pressure erosion without invasion); well-defined margins - "cupping resorption"
• FNAC (Fine Needle Aspiration Cytology): Smears show epithelial cells in a chondromyxoid background - this is virtually diagnostic

---

Histopathological Features (Shafer's - most detailed)

• Encapsulated (fibrous capsule of variable thickness - may be incomplete/thin in some areas)
• Cut surface: grey-white, glistening, with firm to soft areas; myxoid or cartilaginous areas visible
• Multicentric capsular protrusions ("pseudopod projections") - important cause of recurrence

• Ductal (luminal) cells: Cuboidal to columnar cells lining duct-like spaces; form tubules, cords, or sheets
• Myoepithelial cells: Spindle-shaped, stellate ("plasmacytoid" or "hyaline" cells in some variants); form the major cell population; these cells are responsible for producing the stromal matrix
• Cells may form solid nests, trabeculae, or duct-like structures
• Squamous metaplasia may be seen

• The stromal material is produced by myoepithelial cell metaplasia (not true mesenchyme)
• Myxoid stroma - pale, blue-grey mucinous material (most common)
• Chondroid (cartilage-like) areas - characteristic feature; hyaline cartilage with lacunae (distinguishable from true cartilage only in some areas); one of the most characteristic features
• Collagenous (hyalinized) areas - dense pink collagen
• Osseous/bone formation - rare but possible
• Mucoid areas
• The ratio of epithelial to stromal component varies greatly:
  • Cellular type: predominantly epithelial
  • Myxoid type: predominantly stroma
  • Classic mixed: equal components

• Fibrous capsule of variable thickness
• May be incomplete or thin - tumor "pseudopod" projections may penetrate it or extend beyond it
• This is the main reason for recurrence after simple enucleation

---

Treatment (Shafer's)

• Superficial parotidectomy with preservation of the facial nerve - treatment of choice for tumors in the superficial lobe
• Total parotidectomy for deep lobe tumors or large tumors
• Simple enucleation is CONTRAINDICATED - high recurrence due to pseudopod projections through the capsule

• Total excision of the submandibular gland

• Wide local excision with a margin of normal tissue
• Hard palate: excision down to periosteum; periosteum left intact if possible
• Transoral approach

• Never aspirate (can seed tumor cells)
• Never incise (incomplete removal leads to recurrence)
• Never enucleate alone

---

Prognosis (Shafer's)

• Excellent prognosis after adequate surgery
• Recurrence: 1-5% with superficial parotidectomy; up to 20-45% after simple enucleation
• Causes of recurrence: incomplete capsule, pseudopod projections, intraoperative tumor spillage, enucleation
• Malignant transformation (Carcinoma ex pleomorphic adenoma):
  • Occurs in 2-5% of long-standing pleomorphic adenomas
  • Risk increases with duration: 1.5% in <5 years; up to 9.5% in >15 years
  • Warning signs: rapid growth after slow growth, pain, facial nerve palsy, skin fixation
  • Histology: carcinomatous change in epithelial component
  • Prognosis after malignant transformation: poor

---

Q15 / Q24. Classify viral diseases. Discuss in detail the etiopathogenesis, clinical features, histopathology, laboratory investigations, and management of herpes simplex infection.

---

CLASSIFICATION OF VIRAL DISEASES AFFECTING THE ORAL CAVITY

1. Herpes simplex virus type 1 (HSV-1) - Primary herpetic gingivostomatitis; Recurrent herpes labialis; Recurrent intraoral herpes
2. Herpes simplex virus type 2 (HSV-2) - Genital herpes; oral involvement rare
3. Varicella zoster virus (VZV) - Chickenpox; Herpes zoster (shingles)
4. Epstein-Barr virus (EBV) - Infectious mononucleosis; Oral hairy leukoplakia
5. Cytomegalovirus (CMV) - Cytomegalic inclusion disease
6. Human Herpesvirus 6 (HHV-6) - Roseola infantum
7. Human Herpesvirus 8 (HHV-8) - Kaposi's sarcoma

1. Measles (Rubeola) - Koplik's spots
2. Mumps - Parotitis
3. Herpangina (Coxsackievirus A)
4. Hand-foot-and-mouth disease (Coxsackievirus A16, Enterovirus 71)

1. Papillomavirus (HPV) - Squamous papilloma, Condyloma, Verruca vulgaris

1. Rubella
2. HIV/AIDS-related oral lesions

---

HERPES SIMPLEX VIRUS INFECTION

Introduction (Shafer's)

• HSV is a DNA virus belonging to the family Herpesviridae
• Two serotypes: HSV-1 (oro-facial infections) and HSV-2 (genital infections; occasional oral involvement)
• Unique property: ability to establish latency in sensory nerve ganglia after primary infection
• HSV-1 remains latent in the trigeminal ganglion (Gasserian ganglion)
• Reactivation causes recurrent disease
• Ubiquitous - ~80-90% of adults have serological evidence of HSV-1 infection

---

Etiopathogenesis (Shafer's - detailed)

• Double-stranded DNA virus
• Enveloped; 150-200 nm in diameter
• Glycoprotein spikes on envelope mediate cell attachment

1. HSV enters via direct contact with infected secretions (saliva, vesicle fluid) through mucosal surfaces or abraded skin
2. Virus attaches to host cell receptors (heparan sulfate proteoglycans) via glycoproteins gB and gC
3. Viral envelope fuses with cell membrane → viral DNA enters nucleus
4. Viral DNA replication in the nucleus → new viral particles → cell lysis → vesicle formation
5. Cytopathic effect: Nuclear swelling → eosinophilic intranuclear inclusions (Cowdry type A) → multinucleated giant cells (balloon cells) → cell death

1. Virus travels retrograde along sensory nerve axons to the sensory nerve ganglion (trigeminal ganglion for oral HSV-1)
2. In the ganglion, viral DNA remains in episomal form; no replication; no cell death
3. Virus can persist for life

• Triggered by: fever/illness (hence "fever blisters"), sunlight/UV exposure, stress, trauma, immunosuppression, menstruation, fatigue
• Triggers → signal transduction in neurons → viral reactivation → anterograde transport along nerve axons → mucosal/skin replication → lesion at or near the original site

---

Clinical Features

• Most common in children 6 months - 5 years (loss of maternal antibodies)
• Can occur in adults (first exposure/seronegative adults)

• Fever (38-40°C), malaise, headache, anorexia, irritability
• Cervical lymphadenopathy (submandibular nodes enlarged, tender)
• Duration of prodrome: 1-2 days

• Sudden onset of multiple small vesicles throughout the oral cavity
• Vesicles rupture rapidly → shallow, painful ulcers with a yellowish-gray pseudomembranous center and red erythematous halo
• DIFFUSE distribution - any part of the oral mucosa affected: gingiva, labial and buccal mucosa, palate, tongue, lips, pharynx
• Acute herpetic gingivitis: Intense erythema and edema of the marginal and attached gingiva (entire gingiva inflamed - differs from aphthous which spares attached gingiva)
• Ulcers are extremely painful → refusal to eat and drink → dehydration risk in children
• Drooling, fetid breath (halitosis)

• Burning, tingling, itching at the site 12-24 hours before lesion appears (prodromal symptoms due to viral movement along nerve)

1. Erythema/macule → 2. Papule → 3. Vesicle/Blister → 4. Ulcer/Pustule → 5. Crust → 6. Healing (without scarring)

• Total duration: 7-10 days
• Recurrence at or near same site each time

• Less common than herpes labialis
• Occurs on attached/keratinized mucosa (hard palate, attached gingiva) - key distinguishing feature from aphthous ulcers which affect non-keratinized mucosa
• Multiple small clustered ulcers
• Less severe than primary infection
• Patient may be immunocompromised

---

Histopathological Features (Shafer's)

1. Balloon degeneration (ballooning degeneration):
   • Infected epithelial cells swell markedly → clear, pale, swollen cytoplasm
   • Cell membrane ruptures → vesicle contents released between cells
2. Reticular degeneration:
   • Further swelling of cells → rupture of cell walls → multilocular vesicle formation
   • Interconnected spaces (reticular pattern)
3. Acantholysis:
   • Loss of intercellular bridges → individual cells separate and float in vesicle fluid
4. Cowdry Type A intranuclear inclusions (PATHOGNOMONIC):
   • Eosinophilic, homogeneous, ground-glass inclusions within the nucleus
   • Surrounded by a clear halo with margination of chromatin at the nuclear periphery
   • Represents accumulation of viral particles in the nucleus
   • Also called "Lipschutz inclusion bodies" in herpes
5. Multinucleated giant cells (Syncytia):
   • Multiple nuclei within a single large cell
   • Nuclei may show nuclear molding
   • "Tzanck cells" - acantholytic cells with viral inclusions seen in smears
6. Vesicle:
   • Intraepithelial vesicle (within the epithelium, not below the basement membrane)
   • As vesicle develops: fluid fills the space → roof is formed by superficial epithelial layers
   • Inflammatory cells (neutrophils initially, then lymphocytes) in the underlying connective tissue

---

Laboratory Investigations (Shafer's + Hemant Gupta)

1. Tzanck smear (Tzanck test):
   • Scrapings from the base of the vesicle → smear on glass slide → stained with Giemsa
   • Shows: multinucleated giant cells (Tzanck cells) with Cowdry type A inclusions
   • Simple, rapid, bedside test; not type-specific
2. Viral culture:
   • Gold standard for confirmation
   • Vesicle fluid inoculated onto cell culture (Vero cells, MRC-5 cells)
   • Cytopathic effect (CPE) visible in 24-72 hours
3. PCR (Polymerase Chain Reaction):
   • Most sensitive and specific; detects viral DNA
   • Type-differentiates HSV-1 vs HSV-2
   • From vesicle swab, saliva, or CSF
4. Serology:
   • IgM antibodies: Appear in 5-7 days of primary infection; indicates acute/recent infection
   • IgG antibodies: Appear by 3 weeks; persist for life; indicates past exposure
   • Paired sera (4-fold rise in titer): Confirms primary infection
   • Type-specific glycoprotein G (gG) antibody test - distinguishes HSV-1 and HSV-2
5. Immunofluorescence:
   • Direct immunofluorescence (DIF) on smear or biopsy using fluorescent-labeled anti-HSV antibodies
   • Rapid and sensitive
6. Electron microscopy:
   • Shows characteristic herpes viral particles (morphology)
7. Histopathology:
   • Biopsy of lesion showing Cowdry type A inclusions, multinucleated giant cells, intraepithelial vesicle

---

Management (Shafer's)

• Adequate fluid intake (prevent dehydration - especially in children)
• Soft diet, rest
• Analgesics: paracetamol/ibuprofen (NOT aspirin in children - Reye's syndrome)
• Topical anesthetics: viscous lignocaine for pain relief

• Acyclovir 400 mg BD daily (long-term)
• Valacyclovir 500 mg OD daily

• Higher doses of acyclovir; IV acyclovir for severe/disseminated disease
• For acyclovir-resistant HSV: Foscarnet or Cidofovir

• Avoid contact with lesion
• Handwashing
• No kissing/sharing utensils during active lesion

---

Q16 / Q21. Define dental caries. Describe the various theories of aetiopathogenesis of dental caries.

---

DEFINITION (Shafer's)

• G.V. Black's definition: "Dental caries is a microbiologic disease of the calcified tissues of the teeth, characterized by demineralization of the inorganic portion and destruction of the organic substance of the tooth."
• Dental caries is a progressive, irreversible microbial disease of the calcified tissues of the teeth, starting at the tooth surface and proceeding inward

---

CLASSIFICATION OF DENTAL CARIES (Shafer's)

• Class I: Pits and fissures - occlusal surfaces of posterior teeth
• Class II: Proximal surfaces of posterior teeth (mesial/distal)
• Class III: Proximal surfaces of anterior teeth (not involving incisal angle)
• Class IV: Proximal surfaces of anterior teeth (involving incisal angle)
• Class V: Cervical third of all teeth
• Class VI: Cusp tips (added later)

• Acute (rampant) caries
• Chronic caries
• Arrested caries

• Simple caries (1 surface)
• Compound caries (2 surfaces)
• Complex caries (3+ surfaces)

• Primary caries
• Secondary (recurrent) caries
• Radiation caries

---

THEORIES OF AETIOPATHOGENESIS OF DENTAL CARIES (Shafer's - Chapter on Dental Caries)

---

1. CHEMO-PARASITIC THEORY (ACID THEORY)

• Stage 1 (Decalcification): Carbohydrates (sugars) + oral bacteria → lactic acid and other organic acids → decalcification of enamel and dentin
• Stage 2 (Proteolysis): After decalcification, proteolytic microorganisms dissolve the organic matrix (collagen framework)

• Did not identify specific organisms
• Did not explain why caries affects only specific tooth surfaces
• Did not explain the role of the host

---

2. PROTEOLYSIS-CHELATION THEORY

• Step 1: Proteolytic microorganisms attack the organic matrix (enamel lamellae, enamel rods, prism sheaths) first
• Step 2: Products of protein breakdown (including EDTA-like chelating compounds) chelate (complex with) calcium → dissolution of hydroxyapatite at neutral or alkaline pH (no need for acid)

• Not widely accepted; enamel protein content is very low (1-2%)
• Most evidence still supports acid as primary agent

---

3. PROTEOLYSIS THEORY

• Microorganisms with proteolytic enzymes attack the keratin-like protein in enamel lamellae and enamel tufts (these are the "weak zones" of enamel) first
• The organic framework breaks down → then the inorganic mineral dissolves

• Enamel is predominantly inorganic (96%); organic content very small
• Acid production precedes proteolysis in most studies

---

4. THE SPECIFIC PLAQUE HYPOTHESIS AND ROLE OF MICROORGANISMS

• Streptococcus mutans - primary initiator of caries; produces:
  • Lactic acid (homofermentative)
  • Glucosyltransferase (GTF) → synthesizes insoluble glucans from sucrose → plaque matrix
  • Tolerates low pH (aciduric) and produces acid efficiently (acidogenic)
• Lactobacillus species - important in dentinal caries progression (deep caries)
• Streptococcus sobrinus - similar to S. mutans; important for smooth surface caries
• Actinomyces species - important in root caries and in acidogenic plaque

---

5. KEYES' TRIAD (MODERN CONCEPT)

         HOST (Tooth + Saliva)
              ↓
    MICROORGANISM + SUBSTRATE → DENTAL CARIES
              ↑
           TIME

---

6. STEPHAN CURVE (Shafer's - important)

• Describes the pH changes in plaque after a sugar rinse
• Normal resting pH of plaque: ~6.5-7.0
• After sugar exposure: pH drops rapidly to below 5.5 (critical pH) within 2-5 minutes
• Demineralization of enamel occurs below critical pH 5.5
• Remineralization occurs when pH rises above 5.5 (from saliva buffering)
• pH returns to normal in 30-60 minutes
• Significance: Explains why frequent snacking is more cariogenic than eating the same amount of sugar at one time

---

ETIOLOGY OF DENTAL CARIES (Shafer's)

• Presence of S. mutans, Lactobacillus, Actinomyces in plaque
• Plaque pH, plaque maturity

• Sucrose - most cariogenic sugar; unique substrate for GTF to form insoluble glucans
• Frequency of sugar intake more important than total amount
• Physical consistency of food (sticky > liquid > solid)
• Sugar-containing between-meal snacks

• Tooth morphology: Deep pits and fissures trap food and bacteria
• Tooth position and alignment: Crowded teeth - more stagnation areas
• Saliva:
  • Quantity: xerostomia → dramatically increased caries
  • Quality: buffering capacity (bicarbonate, phosphate), antimicrobial proteins (IgA, lactoferrin, lysozyme, peroxidase), calcium and phosphate content
• Enamel composition: Fluoride-substituted hydroxyapatite (fluorapatite) is more resistant to acid dissolution

• Duration of plaque formation
• Frequency of sugar exposure
• Caries does not develop instantaneously - requires time

---

HISTOPATHOLOGY OF ENAMEL CARIES (Shafer's)

---

Q17 / Q20. Describe aetiopathogenesis, clinical features, histopathology, and treatment of oral lichen planus.

---

LICHEN PLANUS - SHAFER'S FRAMEWORK

Introduction (Shafer's)

• Lichen planus is a chronic, recurrent, inflammatory mucocutaneous disease of unknown etiology
• First described by Wilson (1869); oral lesions described by Erasmus Wilson
• Oral lichen planus (OLP) is a potentially malignant disorder - malignant transformation ~0.4-3.7% (mainly erosive OLP)
• Frequency: 0.1-4% of general population
• Name origin: "lichen" (resembles lichens growing on trees) + "planus" (flat)

---

Aetiopathogenesis (Shafer's)

1. Antigen presentation:
   • An unidentified antigen (possibly altered keratinocyte surface antigen, drug, dental material, or viral antigen) is processed by Langerhans cells / dendritic cells
   • Antigen-bearing keratinocytes express MHC class I and II molecules aberrantly
2. T-cell activation:
   • CD4+ helper T cells recognize antigen presented on MHC class II → release IFN-γ, TNF-α
   • CD8+ cytotoxic T cells recognize antigen on MHC class I → kill basal keratinocytes (via perforin/granzyme pathway)
   • CD8+ T cells are the dominant cell type in the lichenoid infiltrate
3. Basal cell destruction:
   • Liquefaction (vacuolar) degeneration of basal cells = the fundamental pathological change
   • Dying basal cells become Civatte bodies (colloid bodies)
4. Chemokine recruitment:
   • TNF-α, RANTES → attract more T cells → self-perpetuating cycle
5. Basement membrane disruption:
   • Fibrinogen deposits in the BM zone (shaggy fibrinogen on DIF)
   • Disrupted BM → split between epithelium and connective tissue → bullous OLP

• Emotional stress and anxiety
• Hepatitis C virus (HCV) - strong epidemiological link
• Drugs: Beta-blockers, NSAIDs, antimalarials, ACE inhibitors, thiazides, gold, methyldopa, penicillamine → lichenoid drug reactions
• Dental restorative materials: Amalgam, composite (contact allergy)
• Graft-vs-host disease (GVHD) - produces OLP-like lesions
• Diabetes, hypertension + erosive OLP = Grinspan syndrome (controversial)

---

Clinical Features (Shafer's - six forms by Andreasen)

• Age: Middle-aged adults; 4th-6th decade most common
• Sex: Females > males (2:1)
• Site: Bilateral buccal mucosa (most common), tongue, gingiva, lips, palate

• Wickham's striae - interlacing white lines in a lacy, annular, or arborizing pattern
• Bilaterally symmetric on buccal mucosa (bilaterality is characteristic)
• Usually asymptomatic
• May have slight burning

• Small white/gray papules (pinhead-sized)
• Precursor to reticular lesions
• Asymptomatic

• Homogeneous white patch resembling leukoplakia
• Usually on dorsal tongue and buccal mucosa
• Some atrophy of tongue papillae

• Diffuse red areas with peripheral white striae
• Burning and soreness
• Common on tongue and gingiva

• Most symptomatic form
• Painful erosions/ulcers with fibrinous (pseudomembranous) base
• Surrounded by radiating striae (helpful diagnostic clue)
• Buccal mucosa, tongue, gingiva
• When gingiva affected: desquamative gingivitis
• Highest malignant potential of all OLP forms

• Vesicles and bullae that rupture rapidly → erosions
• Least common
• More severe form

---

Histopathological Features (Shafer's - Classic description)

• Hyperkeratosis (orthokeratosis in plaque type; parakeratosis in reticular type)
• Irregular acanthosis or atrophy (in erosive type)
• "Saw-tooth" rete ridges - pointed, irregular, serrated rete pegs projecting into the connective tissue (characteristic)
• Liquefaction (vacuolar) degeneration of basal cell layer - vacuoles within and between basal cells; cells appear swollen and pale; this represents the T-cell-mediated destruction of basal cells

• Eosinophilic, rounded, homogeneous bodies in the lower epithelium and superficial lamina propria
• Represent apoptotic (degenerate) keratinocytes
• Pathognomonic feature of lichen planus
• Also present in LP of skin

• Subepithelial band-like (lichenoid) lymphocytic infiltrate - the most important diagnostic feature
• Dense, well-defined band of T lymphocytes (predominantly CD8+) in the upper lamina propria (beneath the epithelium)
• The infiltrate is confined to the superficial zone - does NOT extend deeply
• Infiltrate "hugs" the basement membrane zone
• Occasional plasma cells and macrophages

• Disrupted, thickened, or duplicated in some areas
• Fibrinogen deposition (confirmed on DIF)

1. Saw-tooth rete ridges
2. Band-like lymphocytic infiltrate in superficial lamina propria
3. Liquefaction degeneration of basal cells + Civatte bodies

---

Immunofluorescence (Shafer's)

• Fibrinogen deposited in a shaggy, irregular pattern along basement membrane zone - highly characteristic
• Cytoid bodies may stain for IgM (occasionally IgA, IgG)

• No circulating antibodies (distinguishes from pemphigus and MMP)

---

Treatment (Shafer's + Hemant Gupta)

• No treatment required
• Patient education, reassurance
• Regular 6-monthly follow-up (due to malignant potential)

• Triamcinolone acetonide 0.1% in orabase or carboxymethylcellulose - most widely used
• Fluocinonide 0.05% gel
• Clobetasol propionate 0.05% gel or ointment (most potent topical steroid)
• Applied 2-3 times daily to affected areas after meals

• Prednisolone 40-80 mg/day (tapering course) for acute severe exacerbation
• Steroid-sparing agents for long-term: Dapsone, hydroxychloroquine

• Tacrolimus 0.1% ointment - immunosuppressant; useful for steroid-resistant cases; note: some concern about malignant potential with long-term use
• Pimecrolimus 1% cream

• Triamcinolone acetonide injection into resistant isolated erosive lesions

• Topical cyclosporine rinse (5 mL of 100 mg/mL solution - hold in mouth 2 minutes)
• Topical retinoids
• PUVA therapy (psoralen + UVA) for resistant skin LP

• Identify and remove triggering factors (drugs, amalgam, stress)
• Treat HCV if associated
• Chlorhexidine 0.12% rinse for secondary Candida infection (common complication of topical steroids)
• Antifungals if candidal superinfection

---

Q18. Describe hereditary disorders affecting enamel and dentin.

---

HEREDITARY DISORDERS OF ENAMEL AND DENTIN (Shafer's - Chapter on Anomalies)

---

A. HEREDITARY DISORDERS OF ENAMEL

AMELOGENESIS IMPERFECTA (AI)

Introduction

• A group of hereditary conditions affecting enamel formation (not dentin or cementum)
• Affects both primary and permanent dentitions
• Incidence: 1 in 700 - 1 in 16,000 (varies by population)
• Named by Weinmann, Svoboda, and Cook (1945)

Etiology and Genetics

• Mutations in genes involved in enamel formation:
  • AMELX (X-linked) - encodes amelogenin (primary enamel matrix protein)
  • ENAM (autosomal) - encodes enamelin
  • MMP20 - encodes enamelysin (protease for enamel maturation)
  • KLK4 - encodes kallikrein 4 (protease for enamel maturation)
  • FAM20A, FAM83H, WDR72 - others

Classification (Witkop's Classification - Shafer's)

• Defect in enamel matrix formation (secretory stage defect)
• Normal mineralization but reduced quantity of enamel
• Enamel is hard and well-mineralized but thin, pitted, or absent
• X-ray: enamel visible but thin; good contrast between enamel and dentin
• Sub-types: IA (pitted, autosomal dominant), IB (local, AD), IC (local, AR), ID (smooth, X-linked dominant), IE (smooth, AR), IF (rough, AD), IG (enamel agenesis, AR)

• Defect in enamel maturation (removal of matrix proteins and water)
• Enamel is normal thickness but soft and discolored (speckled white, yellow, or brown)
• Enamel has normal volume but abnormal mineral content → can be pierced by explorer
• X-ray: Enamel density approaches dentin (reduced opacity; enamel and dentin appear similar)
• Includes X-linked (snow-capped teeth), autosomal recessive

• Defect in initial calcification/mineralization
• Enamel is normal thickness but extremely soft (chalky, cheesy consistency)
• Enamel chips and wears rapidly after eruption → dentin exposed
• Most severely affected clinically
• X-ray: Enamel density LESS than dentin (enamel appears darker than dentin)
• Autosomal dominant or recessive
• Enamel can be scraped off with a blunt instrument

• Mixed features; associated with taurodontism

---

Clinical Features (General for AI):

• All teeth affected (both dentitions)
• No other systemic associations (pure dental anomaly)
• Sensitivity to temperature changes (exposed dentin)
• Open bite may develop (posterior teeth wear down rapidly)
• Aesthetic concern: Discolored, malformed teeth → significant psychological impact
• Gingival hyperplasia may occur (especially in hypocalcified type)
• Anterior open bite - characteristic in some hypoplastic types

Histopathology:

• Hypoplastic: Enamel rods present but fewer in number; enamel thin; rod structure may be disorganized
• Hypomature: Enamel rods present, normal thickness; reduced density of crystallites; protein remnants in interrod spaces
• Hypocalcified: Enamel rods poorly defined; large areas of non-mineralized matrix; enamel soft

Treatment:

• Primary teeth: Composite/GIC restorations to improve function and esthetics
• Permanent teeth: Full coverage crowns (stainless steel crowns in children; porcelain-fused-to-metal or all-ceramic in adults)
• Overdentures for severely affected cases
• Multidisciplinary approach (ortho, perio, prosthetics)

---

B. HEREDITARY DISORDERS OF DENTIN

DENTINOGENESIS IMPERFECTA (DI)

Introduction

• A hereditary condition affecting dentin formation in otherwise normal individuals
• Also called "hereditary opalescent dentin"
• Incidence: 1 in 6,000-8,000
• Named by Shields (1973) who classified it into three types

Shields Classification (Shafer's)

Genetics (Type II):

• DSPP gene mutation (Dentin Sialophosphoprotein gene on chromosome 4q21)
• DSPP encodes dentin sialoprotein and dentin phosphoprotein - key dentin matrix proteins
• Autosomal dominant (high penetrance)

Clinical Features (Shafer's)

• Affects both primary and permanent dentitions (primary > permanent in severity)
• Teeth have an amber/brown/blue-gray or opalescent (translucent, pearlescent) color - "shield's opalescence"
• The opalescent quality is due to light scattering by abnormal dentin
• Primary teeth affected more severely than permanent
• Rapid wear (attrition): Enamel fractures off (due to lack of scalloped DEJ support) → dentin exposed → rapidly wears down
• Crowns appear bulbous (large, round crown with constricted cervix)
• Roots appear short and blunted
• Pulp obliteration:
  • Pulp chambers and root canals are progressively obliterated by continued deposition of abnormal dentin
  • In young teeth: pulp chambers may appear large initially; later obliterate
  • This makes endodontic treatment difficult

Radiographic Features:

• Characteristic bulbous crowns with constricted cervical region
• Short, blunted, tapering roots
• Obliteration of pulp chambers and root canals (most characteristic X-ray feature)
• Periapical pathology may develop despite vital pulp (due to defective dentin protecting pulp poorly)

Histopathological Features:

• Mantle dentin: Normal (outermost layer of dentin is relatively normal)
• Remaining dentin: Markedly abnormal
  • Tubular architecture disrupted - few, irregular, poorly formed dentinal tubules
  • Large areas of atubular dentin
  • Dentin formed too rapidly → cells get trapped → entrapped cell inclusions
  • Poorly calcified areas with irregular, large mineralization foci
• DEJ (Dentino-enamel junction): Flat (lacks normal scalloping) → enamel has no mechanical lock → fractures easily

Treatment:

• Primary teeth: Stainless steel crowns early - protect from wear
• Permanent teeth: Full coverage crowns; overdentures
• Prevent attrition from the earliest opportunity
• Regular monitoring

---

DENTIN DYSPLASIA (DD)

Shields Classification:

---

Q19 / Q23. Enumerate vesiculobullous lesions. Describe pathogenesis, clinical features, lab investigations, and differential diagnosis of pemphigus vulgaris.

---

CLASSIFICATION OF VESICULOBULLOUS LESIONS (Shafer's)

1. Pemphigus vulgaris
2. Pemphigus vegetans
3. Pemphigus foliaceus
4. Paraneoplastic pemphigus

1. Mucous membrane pemphigoid (Benign mucous membrane pemphigoid / Cicatricial pemphigoid)
2. Bullous pemphigoid
3. Dermatitis herpetiformis
4. Linear IgA disease
5. Epidermolysis bullosa (hereditary)
6. Lichen planus (bullous type)
7. Erythema multiforme
8. Angina bullosa haemorrhagica

---

PEMPHIGUS VULGARIS

Introduction (Shafer's)

• Pemphigus is a group of potentially life-threatening autoimmune mucocutaneous diseases characterized by loss of intercellular cohesion (acantholysis) within the epithelium → intraepithelial blister formation
• Pemphigus vulgaris (PV) is the most common form (~80% of all pemphigus)
• Before steroids were introduced: nearly always fatal (from secondary infection, dehydration, electrolyte imbalance)
• Name: from Greek "pemphix" = bubble/blister

---

Etiology and Pathogenesis (Shafer's - Autoimmune Mechanism)

• PV is caused by IgG autoantibodies directed against desmosomal proteins on the keratinocyte surface

• Desmoglein 3 (Dsg3) - 130 kDa transmembrane glycoprotein of the desmosome
  • Target in mucosal-dominant PV (oral-only involvement)
• Desmoglein 1 (Dsg1) + Desmoglein 3 (Dsg3) - target in mucocutaneous PV (skin + mucosa)
• Desmoglein 1 alone → Pemphigus foliaceus (only skin, no mucosa since Dsg1 not expressed in oral mucosa)
• Desmoglein compensation theory (Mahoney): Explains why only mucosa OR skin OR both are affected depending on which desmogleins are targeted and where they are expressed

1. IgG autoantibodies bind to extracellular domain of Dsg3 on keratinocyte surface
2. Sterically hinder desmoglein-desmoglein binding between adjacent cells
3. Additional mechanisms: complement activation, antibody-mediated signal transduction, serine protease activation (plasminogen activator)
4. Desmosomes dissolve → intercellular cohesion lost → acantholysis
5. Fluid accumulates between separated keratinocytes → intraepithelial blister

• HLA class II association: HLA-DR4 (DRB1*0402) and HLA-DR14 most strongly associated
• HLA alleles → present Dsg3 peptides to T cells → autoimmune response initiated

• Drugs: penicillamine, captopril, rifampicin, penicillin, piroxicam (drug-induced pemphigus)
• Ultraviolet radiation
• Thiol-containing foods (garlic, leeks)
• Physical trauma
• Psychological stress
• Viral infection (EBV, HSV)

---

Clinical Features (Shafer's)

• Incidence: 0.1-0.5 per 100,000/year
• Age: Usually 4th-6th decade (40-60 years); rare in children
• Sex: Slight female predominance or equal
• Ethnicity: More common in Ashkenazi Jews, Mediterranean populations, Indians

• Oral lesions precede skin lesions by weeks to months - very important clinically
• Large, flaccid bullae that rupture almost immediately
• The vesicles/bullae are thin-roofed → rupture with minimal trauma → erosions
• Resulting irregular, ragged, painful erosions with erythematous base and shredded epithelial tags at the margins
• Site: Any oral mucosal surface - buccal mucosa, soft palate, oropharynx most common; also labial mucosa, ventral tongue
• Gingival involvement: Desquamative gingivitis - intensely erythematous, friable gingiva; Nikolsky sign positive on gingiva
• Lesions do NOT scar (unlike MMP)
• New lesions form as old ones heal → chronic, recurrent course
• Severe pain → dysgeusia, odynophagia, difficulty eating/speaking
• Halitosis

• Application of lateral pressure to apparently normal mucosa adjacent to a lesion → new blister/cleavage forms
• Positive in pemphigus vulgaris (intraepithelial blistering, loose attachment)
• Also positive in other acantholytic/subepithelial diseases

• Pressure on the top of an intact bulla → bulla extends to adjacent areas
• Positive in pemphigus

• Flaccid bullae on normal or erythematous skin
• Rupture → painful raw, bleeding erosions
• Sites: scalp, face, trunk, pressure areas, oral cavity, genitalia
• May become extensive and weeping → risk of secondary infection → sepsis

• Larynx, pharynx, esophagus, conjunctiva, genitalia, nasal mucosa may be involved

---

Histopathological Features (Shafer's)

1. Acantholysis:
   • Loss of intercellular bridges (desmosomal dissolution)
   • Keratinocytes separate from each other
   • Individual keratinocytes round up → Tzanck cells (acantholytic cells)
2. Level of cleft:
   • Cleavage occurs in the lower stratum spinosum, just above the basal cell layer (suprabasilar cleavage)
   • Basal cells remain attached to the basement membrane like a "row of tombstones" (tombstone pattern)
3. Tzanck cells (Acantholytic cells):
   • Large, round cells floating in the vesicle fluid
   • Enlarged, hyperchromatic nucleus with prominent nucleolus
   • Condensed, densely eosinophilic cytoplasm (cell shrinks and rounds up)
4. Connective tissue:
   • Preserved; no damage to basement membrane
   • Inflammatory infiltrate: Eosinophils (characteristic), lymphocytes, and neutrophils in lamina propria
5. Eosinophilic spongiosis:
   • Early lesion: eosinophils migrate between keratinocytes (eosinophilic spongiosis) before frank acantholysis

---

Laboratory Investigations (Shafer's + Hemant Gupta)

• Scrapings from base of fresh bulla → smeared on glass slide → stained (Giemsa or H&E)
• Shows: Tzanck cells (acantholytic cells) - large, rounded, with enlarged hyperchromatic nucleus
• Simple, rapid bedside test
• Not definitive - cannot distinguish type of pemphigus or from other acantholytic diseases

• Perilesional biopsy (adjacent to lesion - not from center of erosion which shows non-specific changes)
• Shows: suprabasilar cleavage, acantholysis, tombstone row of basal cells, Tzanck cells, eosinophilic infiltrate
• Gold standard for diagnosis

• Perilesional biopsy processed with fluorescent antibodies
• Pattern: Intercellular/net-like/fishnet pattern of IgG (and C3) deposition throughout the spinous layer of the epithelium
• This "chicken wire" or "cobblestone" pattern is pathognomonic of pemphigus
• IgA may replace IgG in IgA pemphigus
• Sensitivity: ~90%

• Patient's serum placed on epithelial substrate (monkey esophagus or guinea pig lip)
• Circulating anti-Dsg3 IgG autoantibodies detected in ~80-90% of active PV
• Titer correlates with disease activity - useful for monitoring treatment response

• Detects and quantifies anti-Dsg1 and anti-Dsg3 antibodies in serum
• More sensitive and specific than IIF
• Useful for: confirming diagnosis, monitoring treatment, predicting relapse

• Leukocytosis (if secondary infection)
• Eosinophilia (sometimes)
• Anemia in severe cases

• Hypoalbuminemia (protein loss through erosions)
• Electrolyte imbalance (Na+, K+) in severe cases

• Positive in pemphigus

---

Differential Diagnosis

---

Treatment (Shafer's)

• Corticosteroids - mainstay: Prednisolone 1-2 mg/kg/day; taper slowly
• Steroid-sparing agents: Azathioprine (most common), mycophenolate mofetil, cyclophosphamide, dapsone, gold
• Rituximab (anti-CD20 monoclonal antibody) - for refractory cases; highly effective (depletes B cells → reduces autoantibody production)
• Intravenous immunoglobulin (IVIg) for refractory cases

• Topical triamcinolone acetonide in orabase
• Dexamethasone rinse/elixir
• Chlorhexidine rinse for oral hygiene

---

Q22. Discuss etiology, clinical features, histopathological features, and treatment of fibrous dysplasia. Add a note on associated syndromes.

---

FIBROUS DYSPLASIA (Shafer's Framework)

---

ASSOCIATED SYNDROMES (Shafer's - additional exam section)

• Classic triad:
  1. Polyostotic fibrous dysplasia (multiple bones)
  2. Café-au-lait skin macules with irregular ("coast of Maine") border - distinguishes from neurofibromatosis whose spots have smooth "coast of California" borders
  3. Endocrine abnormalities:
     • Sexual precocity (precocious puberty) - most common endocrine feature; more common in females
     • Hyperthyroidism
     • Acromegaly (excess GH)
     • Cushing syndrome
     • Hyperprolactinemia
• Caused by post-zygotic GNAS mutation early in embryogenesis
• Prognosis: Variable; depends on extent of skeletal and endocrine involvement

• Fibrous dysplasia (monostotic or polyostotic) + intramuscular myxomas
• Myxomas are benign soft tissue tumors arising in muscles near the affected bone
• Rare; more common in females
• Myxomas may be multiple
• Treatment: excision of symptomatic myxomas; FD managed separately

• Not a "syndrome" per se, but a distinct form
• Monostotic or polyostotic involvement of craniofacial skeleton (skull, facial bones, jaw)
• Jaw (especially maxilla) is a common site
• Complications: visual disturbance (orbital involvement), deafness (temporal bone), nasal obstruction
• Important in BDS context

• Tooth displacement is more common than root resorption
• Mandibular canal may be displaced
• Root morphology normal
• Periodontal membrane space intact (helpful in distinguishing from osteomyelitis)
• Lab: serum ALP may be mildly elevated in active polyostotic disease; calcium and phosphorus normal
• Radiation therapy CONTRAINDICATED (risk of malignant transformation to sarcoma)
• Surgery timing: after puberty when growth stabilizes; earlier only if functional impairment

---

Q25. Write sequelae of pulpitis. Describe in detail the clinical features, radiographic features, histopathological features, and microbiological features of periapical granuloma.

---

SEQUELAE OF PULPITIS (Shafer's)

DENTAL CARIES / PULPAL INFECTION
        ↓
PULPITIS (Reversible → Irreversible)
        ↓
PULP NECROSIS (death of pulpal tissue)
        ↓
PERIAPICAL PATHOLOGY:
  ├── Periapical Granuloma (most common)
  ├── Periapical Abscess
  │   ├── Acute dentoalveolar abscess
  │   └── Chronic dentoalveolar abscess
  │       └── With sinus tract (parulis / gumboil)
  ├── Periapical Cyst (Radicular cyst - most common jaw cyst)
  └── Periapical Condensing Osteitis (Focal sclerosing osteomyelitis)

1. Pulp hyperemia (reversible; earliest change)
2. Acute pulpitis (reversible or irreversible)
3. Chronic pulpitis
4. Pulp necrosis (liquefactive or coagulative)
5. Periapical granuloma (most common)
6. Periapical abscess (acute: pus; chronic: draining sinus)
7. Radicular cyst (from epithelial rest proliferation in granuloma)
8. Osteomyelitis (if untreated spread)

---

PERIAPICAL GRANULOMA

Introduction (Shafer's)

• Most common sequel of pulp necrosis and pulpitis
• A chronic periapical inflammatory lesion consisting of granulomatous tissue
• NOT a true granuloma in the histological sense (not granulomatous inflammation with epithelioid cells) - it is a chronic inflammatory mass
• More accurately called "periapical inflammatory granulation tissue" or "chronic apical periodontitis"
• Most common periapical pathology (accounting for ~50% of periapical lesions)
• Represents the body's attempt to wall off and localize the spread of infection from the root canal

---

Etiology (Shafer's)

• Bacteria and their toxins (LPS, peptidoglycans, enzymes)
• Byproducts of pulp necrosis (H2S, skatole, indole, butyric acid)
• Antigenic materials from necrotic pulp → immune reaction
• Chemical irritants from root canal treatment (chronic cases)

• Deep caries with pulp involvement
• Trauma (tooth fracture with pulp exposure)
• Periodontitis with deep pocket → retrograde pulpitis
• Failed root canal treatment

---

Clinical Features (Shafer's)

• Usually asymptomatic (silent lesion) - most commonly discovered on routine radiograph
• May have slight tenderness to percussion (mild, dull)
• No spontaneous pain (differentiates from acute apical abscess)
• The causative tooth is non-vital (negative response to pulp vitality tests - cold, EPT)
• Deep caries, discoloration, or failed restoration usually visible
• No swelling, no sinus tract (unless secondarily infected → becomes acute or chronic abscess)
• Occasional mild pain on biting
• Tooth may be slightly elongated (due to increased fluid in PDL space)

---

Radiographic Features (Shafer's)

• Periapical radiolucency - well-defined or diffuse, at the apex of the tooth
• Size: Small to moderate (usually <1.5-2 cm); periapical cysts tend to be larger
• Shape: Rounded or oval; may be slightly irregular
• Borders: May be well-defined (sclerotic rim) or diffuse (active/recent)
• Loss of lamina dura at the tooth apex (normally a continuous white line around root)
• PDL space widening at the apex
• Cortical bone intact (granuloma does not cause cortical perforation)
• Root resorption may or may not be present (more common with cysts)
• Important: Periapical granuloma and periapical cyst cannot be reliably distinguished radiographically - histopathology is definitive

---

Histopathological Features (Shafer's - detailed)

• Soft, pink-red, granulation-like tissue
• Attached to root apex via periodontal ligament fibers
• Slightly firm; bleeds when cut

• Granulation tissue - highly vascular connective tissue
• Newly formed capillaries, fibroblasts
• Inflammatory infiltrate: Predominantly lymphocytes and plasma cells (chronic inflammation)
• Macrophages (including foam cells) and occasional neutrophils
• Hemosiderin deposits (from old bleeding)
• Cholesterol clefts: Needle-like clefts or spaces where cholesterol crystals dissolved during processing; surrounded by foreign body giant cells; result from breakdown of red blood cells and lipid-rich membranes

• Dense fibrous capsule (zone of fibrous encapsulation) - separates lesion from surrounding normal bone
• This fibrous wall is formed by the PDL fibers

• Epithelial rests of Malassez (remnants of Hertwig's epithelial root sheath) may proliferate within the granuloma
• Initially appear as isolated strands or cords of epithelium
• When these rests proliferate and form a cavity → radicular cyst begins to develop
• This is why periapical granuloma is the precursor to radicular cyst
• Epithelium present in ~30-50% of periapical granulomas

• Foam cells (lipid-laden macrophages) = "xanthoma cells"
• Dystrophic calcification may occur in long-standing lesions
• Hyaline bodies (Rushton bodies) - curved, linear, hyaline structures in epithelium (of unknown origin)
• Russell bodies: Eosinophilic, round inclusions in plasma cells (immunoglobulin accumulation)

---

Microbiological Features (Shafer's)

• The periapical granuloma itself is sterile or has minimal organisms in the tissue (organisms are primarily within the root canal)
• Organisms reach periapex via: bacterial toxins and byproducts from root canal, or occasionally actual bacterial invasion of periapical tissues

• Anaerobes (predominant):
  • Porphyromonas gingivalis
  • Fusobacterium nucleatum
  • Prevotella intermedia
  • Peptostreptococcus species
  • Treponema species (spirochetes)
• Facultative anaerobes:
  • Streptococcus species (especially in acute flare-ups)
  • Lactobacillus species
  • Actinomyces species (associated with refractory periapical pathology)
• Predominantly polymicrobial infection (mixed flora)

• Particularly important in failed root canal treatment cases
• Tolerates high pH and desiccation
• Forms biofilm within dentinal tubules
• Major cause of persistent/recurrent periapical infection

• Candida species may be found in some cases (especially immunocompromised)

---

Treatment (Shafer's)

• Root canal treatment (RCT/endodontic therapy) - eliminates the source of irritation (infected root canal contents)
  • Biomechanical preparation → chemomechanical irrigation (NaOCl, EDTA, chlorhexidine) → obturation
  • Resolution of periapical granuloma expected within 6-12 months post-RCT
• Periapical surgery (Apicoectomy) - indicated when:
  • RCT fails to resolve the lesion
  • Non-negotiable canals
  • Large lesion not responding to conservative treatment
  • When histopathological confirmation needed (to rule out cyst or malignancy)
• Extraction - when tooth is non-restorable

• Radiographic review at 6 months and 1 year post-RCT
• Complete healing expected by 1-2 years; healing if PDL space normalizes and lamina dura reforms

---

📋 SUMMARY - Q13 to Q25

---

• Q15 and Q24 are the same answer (Herpes) - use one answer for both
• Q16 and Q21 are the same (Dental caries) - same answer
• Q17 and Q20 are the same (OLP) - same answer
• Q19 and Q23 have slight differences: Q19 asks for pemphigus specifically; Q23 asks for vesiculobullous classification first, then PV - start Q23 with the full vesiculobullous classification table before going into PV